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RÉSUMÉ 
 ii
Le syndrome reproducteur et respiratoire porcin (SRRP) est une des maladies 
les plus dévastatrices économiquement pour l'industrie mondiale du porc. L'agent 
étiologique du SRRP est le virus du SRRP (VSRRP) lequel est connu pour avoir une 
spécificité d'hôte très restreinte et pour sa transmission par voie aerosol. Les antigènes 
et les ARN du VSRRP ont été trouvés dans des cellules épithéliales du tractus 
respiratoire de porcs infectés par le virus. L’interaction entre les macrophages 
alvéolaires porcins (PAMs) et le VSRRP a été démontrée comme jouant un rôle 
important dans l’infection causée par le virus. Malgré cela, l’interaction prenant place 
entre les cellules épithéliales du tractus respiratoire porcin et le virus ne devrait pas 
être négligée. Jusqu’à présent, la réplication du VSRRP in vitro dans des cellules 
épithéliales du tractus respiratoire porcin n’a pas été conduite avec succès et les 
tentatives pour le faire ont échoué. Une nouvelle lignée de cellules épithéliales de 
poumon de porc (SJPL) est maintenant disponible et sera utilisée dans cette étude afin 
de déterminer si elle est permissive à la réplication du VSRRP et si elle peut être un 
modèle approprié pour l’étude de la pathogénèse virale du VSRRP. L’expérimentation 
a démontré que cette nouvelle lignée cellulaire était permissive à l’infection et à la 
réplication du VSRRP. Afin de corroborer ces résultats, la cinétique de réplication du 
virus à été effectuée avec les cellules MARC-145 et SJPL. Aucune différence 
significative dans la production virale totale n’a été trouvée entre les deux lignées 
cellulaires. Les cellules SJPL ont permis la réplication de plusieurs souches Nord-
Américaines du VSRRP, quoiqu’elles sont légèrement moins efficaces que les cellules 
MARC-145 pour l’isolement du virus. De plus, les cellules SJPL sont 
phénotypiquement différentes des cellules MARC-145. Plus précisément, les cellules 
SJPL sont plus sensibles à l’activation par le VSRRP des pro-caspases 3/7 et plusieurs 
inducteurs apoptotiques. Elles ont également montré de 8 à 16 fois plus de sensibilité à 
l’effet antiviral causé par l’IFN-α sur la réplication du virus contrairement aux cellules 
MARC-145. Ces résultats démontrent que les cellules SJPL pourraient représenter un 
substitut intéressant aux cellules MARC-145 pour la production d’antigènes pour un 
vaccin anti-VSRRP. Également, dû à leurs origines (poumon de l’hôte naturel), elles 
pourraient s’avérer être un modèle in vitro plus approprié pour l’étude de la 
pathogénèse du VSRRP. 
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ABSTRACT 
 
 
 
 
 
 
 
 
 
 
  
v
Porcine reproductive and respiratory syndrome (PRRS) is one of the most 
economically devastating diseases for the pig industry worldwide. The etiological 
agent of PRRS is the PRRS virus (PRRSV), which is known to have a very restricted 
host specifity and to be airborne transmitted. PRRSV RNAs and antigens were found 
in epithelial cells of the respiratory tract of swine in PRRSV-infected pigs. Even if the 
interaction between porcine alveolar macrophages (PAMs) and PRRSV plays an 
important role in the PRRSV infection, the role of the interaction between epithelial 
cells of the swine respiratory tract and PRRSV should not been neglected. However, 
no epithelial cells of the swine respiratory tract have been demonstrated to allow 
PRRSV replication in vitro and attempts to generate such a cell line have failed. The 
goal of this study is to determine whether epithelial cells of the swine respiratory tract 
are permissive to PRRSV replication and are a suitable model for studying the viral 
pathogenesis of PRRSV. We have discovered that the SJPL cell line, an epithelial cell 
line of the respiratory tract of swine, is permissive to PRRSV infection and replication.  
To corroborate these results, PRRSV replication kinetics were evaluated in a subclone 
of the African green monkey kidney MA104 cells (MARC-145), which has been 
known to be fully permissive to PRRSV infection and replication, and in SJPL cells. 
No significant difference was found between the two cell lines for overall viral 
production. Moreover, the SJPL cells were able to permit the replication of several 
PRRSV North-American strains but they were slightly less efficient for virus isolation 
than MARC-145 cells. In addition, SJPL is phenotypically different from MARC-145. 
Specifically, the SJPL cells were more sensitive to procaspases 3/7 activation by 
PRRSV and several apoptotic inducers compared to MARC-145 cells. In addition, the 
SJPL cells showed 8 to 16 times more sensitivity to the antiviral effect of IFN-α 
against PRRSV replication than MARC-145 cells. Altogether, the SJPL cells could be 
an interesting substitute to MARC-145 cells for PRRSV vaccine antigen production, 
and could be a more relevant in vitro model, because of their origin (lung of the natural 
host), to study the pathogenesis of PRRSV. 
 
Key words: Porcine reproductive and respiratory syndrome virus; PRRSV; porcine 
lung epithelial cell; SJPL; virus replication; cell permissiveness 
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Porcine reproductive and respiratory syndrome (PRRS) is one of the most 
economically devastating diseases for the pig industry worldwide (Garner et al., 2001; 
Neumann et al., 2005; Pejsak et al., 1997). The disease was first reported in the United 
States in 1987 (Keffaber, 1989; Loula, 1991) and in Europe in the early 1990s (OIE, 
1992). Since then, it has spread throughout the world and has caused huge economic 
losses in swine industry. The etiologic agent, PRRS virus (PRRSV) was identified by 
investigators in the Netherlands and USA in 1991 (Benfield et al., 1992; Wensvoort et 
al., 1991b). PRRS has become a well-recognized global swine disease (Albina, 1997; 
Botner et al., 1994; Hopper et al., 1992; Kuwahara et al., 1994; Tian et al., 2007). In 
the recent years, new PRRSV variants emerged in Vietnam and China causing 
unprecedented large-scale outbreaks and catastrophic clinical syndromes (Feng et al., 
2008; Tian et al., 2007).  
PRRSV is believed to replicate in specific cells both in vivo and in vitro. The 
presence of PRRSV antigens and RNAs has been shown in different cells types in vivo 
by immunohistochemistry (IHC) or in situ hybridization (ISH) (Halbur et al., 1995a; 
Magar et al., 1993; Pol et al., 1991; Rossow et al., 1996; Sur et al., 1997). In vitro, 
PRRSV replicates in primary cultures of PAMs as well as freshly isolated blood 
monocytes or monocytic derived dendritic cells (Voicu et al., 1994; Wang et al., 2007; 
Wensvoort et al., 1991b). Only two other non-porcine permissive cell lines permit the 
replication of PRRSV, the MARC-145 and CL2621 cells (subclones of MA104 
monkey kidney cell line) (Bautista et al., 1993; Benfield et al., 1992; Kim et al., 1993) 
which are routinely used for in vitro propagation of PRRSV and for large scale 
production of PRRSV vaccine. It is well known that the respiratory tract is the primary 
route of PRRSV infection and transmission, and intranasal inoculation was used for 
experimental infections to support this idea (Brockmeier  et al., 2000; Magar et al., 
1995; Meredith, 1993; Wensvoort et al., 1992). Since PRRSV antigens could be found 
in the epithelial cells of the respiratory tract of infected swine, it can be speculated that 
these cells may favor the propagation of PRRSV in vitro. However, to our best 
knowledge, until now, no epithelial cell of the respiratory tract of swine has been 
reported to be permissive to PRRSV replication in vitro. 
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The goals of the present study were: (1) to determine if the PRRSV natural cell 
host of the respiratory tract of swine, the epithelial cells, could support PRRSV 
replication in vitro; (2) to establish a new in vitro PRRSV permissive cell model for 
studying the viral pathogenesis of PRRSV. 
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1. Disease history and terminology 
 
In the late 1980's, catastrophic outbreaks of a previously unrecognized disease 
in pigs were reported in the United States (Keffaber, 1989; Loula, 1991) where it 
became widespread, with subsequent extension into Canada (Bilodeau et al., 1991). 
First described in herds in North Carolina, the syndrome included severe reproductive 
losses, extensive postweaning pneumonia, reduction of growth performance, and 
increased mortality (Hill, 1990). In the absence of a recognized cause, the name 
"Mystery Swine Disease" (MSD) came into common usage (Hill, 1990). In Europe, 
clinical outbreaks notably similar to MSD were reported in November 1990 near 
Munster, Germany (OIE, 1992), in the Netherlands in January 1991 and in Belgium in 
March 1991 (OIE, 1992), but no link was found between outbreaks in Germany and 
MSD in the U.S. (Anon, 1991). Subsequently, disease was found in Spain (Plana et al., 
1992),  Great Britain (Edwards et al., 1992), France (Baron et al., 1992), Denmark 
(Botner et al., 1994), Poland (Pejsak and Markowska-Daniel, 1996) and Czech 
Republic (Valicek et al., 1997). In Asia, outbreaks occurred in Japan in 1988 (Hirose et 
al., 1995), in Taiwan in 1991 (Chang et al., 1993) and in China in 1995 (Tong and Qiu, 
2003). Thus, the pandemic had spread to most of the major swine producing countries 
of the world during a short period of time. Initially, a variety of etiologies for MSD 
were proposed (Bane and Hall, 1990; Daniels, 1990; Hoeffling, 1990; Joo, 1988; Joo, 
1990; Quaife, 1989; Reotutar, 1989). In Canada, a new subtype of Influenza A virus 
was isolated from piglets suffering from severe respiratory disease and added to the list 
as a possible agent of MSD (Dea et al., 1992; Elazhary et al., 1991). Identifying the 
etiology was complicated by the fact that one or more of the suspected pathogens, as 
well as other infectious agents, were commonly isolated from cases of MSD. The lack 
of a specific etiologic agent combined with various clinical signs led to the use of 
several disease names, such as blue ear disease (Paton et al., 1991; Wensvoort et al., 
1991a), mystery swine disease (MSD) (Hill, 1990; Reotutar, 1989), porcine epidemic 
abortion and respiratory syndrome (PEARS) (Pol et al., 1991; Terpstra et al., 1991), 
swine infertility and respiratory syndrome (SIRS) (Benfield et al., 1992; Christianson 
et al., 1992; Collins et al., 1992), pig plaque (Keffaber, 1989) and new pig disease 
(Meredith, 1992).  One virus first isolated in the Netherlands (Wensvoort et al., 1991b) 
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was designated Lelystad (LV) and later another virus isolated from sick swine by a 
team of researchers from South Dakota State University, the University of Minnesota, 
and Boehringer Ingelheim Animal Health was named Swine Infertility and Respiratory 
Syndrome (SIRS) virus. Both virus isolates were shown to induce reproductive failure 
and respiratory signs under experimental conditions (Collins et al., 1992; Terpstra et 
al., 1991), but in May of 1992, participants at the International Symposium on SIRS in 
Minneapolis, Minnesota, chose to name the disease the porcine reproductive and 
respiratory syndrome (PRRS), and since then the agent has been referred to as the 
PRRS virus (PRRSV).  
 Today, PRRS is endemic in the global swine producing countries and has 
become one of the most important pathogens causing economic losses in the swine 
industries (Albina, 1997; Blaha, 2000; Neumann et al., 2005). PRRSV was diagnosed 
in Africa for the first time in June 2004 following outbreaks in Western Cape 
Province, South Africa (OIE, 2005b). Serologic tests did not identify additional 
infected sites at that time but new outbreaks were identified in October 2005 (OIE, 
2005a) and again in August 2007 (Beltran-Alcrudo et al., 2007). Chile is on the verge 
of becoming the first country to eradicate PRRSV. Chilean producers are currently in 
the process of culling all sows that were present at the time of infection (Anon, 2007). 
Sweden claimed to be free of PRRS until 2007 when the disease was recognized as an 
emerging disease (Carlsson et al., 2009). Most recently, new PRRSV variants emerged 
and circulated in Vietnam and China causing unprecedented large-scale outbreak and 
catastrophic clinical syndromes (Feng et al., 2008; Tian et al., 2007; Zhou et al., 2008). 
Some countries, including Switzerland, New Zealand, and Australia, claim to be free 
of the disease (Cannon et al., 1998; Elvander et al., 1997; Garner et al., 1996; Motha et 
al., 1997). 
 
2. Clinical manifestation 
 
PRRS is characterized by anorexia, fever and abortion late in gestation, 
premature births, stillbirths, and mummified fetuses. However, the two most prevalent 
clinical signs are severe reproductive failure in sows and gilts (characterized by late-
term abortions, an increased number of stillborns, mummified and weak-born pigs) 
(Bilodeau et al., 1991; Christianson et al., 1992; Keffaber, 1989; Pol et al., 1991; 
Terpstra et al., 1991) and respiratory problems in pigs of all ages associated with a 
 
 7
non-specific lymphomononuclear interstitial pneumonitis (Bilodeau et al., 1991; 
Collins et al., 1992; Halbur et al., 1995b; Halbur et al., 1996b; Rossow et al., 1994). 
Furthermore, the intensity of the disease appears to vary among isolates and variation 
in PRRSV virulence has been observed in experimentally infected animals (Halbur et 
al., 1995b; Mengeling et al., 1996). Studies showed that pigs experimentally infected 
with different isolates developed major differences in clinical disease, rectal 
temperatures, and gross and histological lung lesions; mildly virulent isolate infections 
induced transient pyrexia, dyspnea and tachypnea, whereas highly virulent isolate 
infections exhibited labored breathing, pyrexia, lethargy, and anorexia (Halbur et al., 
1995a; Halbur et al., 1995b; Halbur et al., 1996b). Moreover, highly virulent isolates 
of PRRSV infection resulted in longer periods of viremia, increased severity of clinical 
signs and mortality, and significantly higher viral loads in blood and tissues (Johnson 
et al., 2004). Several other factors such as animal age and bacterial co-infection can 
influence virus replication and clinical signs. Infection of younger animals showed a 
longer viremia, as well as higher excretion rates and replication rates in macrophages 
compared to the older pigs (Thanawongnuwech et al., 1998; van der Linden et al., 
2003).  Additionally, certain bacteria appeared to enhance the duration and severity of 
PRRSV induced clinical signs (Brockmeier  et al., 2000; Thacker et al., 1999). Host 
immune status may also affect the severity of the clinical signs. Previous exposure to 
PRRSV can prevent the development of PRRS clinical signs by subsequent infection 
with the homologous PRRSV (Shibata et al., 2000).   
 
3. Etiology 
 
3.1. Taxonomy 
  
   The first PRRSV isolates obtained in Europe and North America were 
designated Lelystad and ATCC VR-2332 respectively. Now PRRSV is divided into 
two distinct genotypes, the European (EU) type (or type I) and North American (NA) 
type (or type II). The EU and NA genotypes of PRRSV share only 63% nucleotide (nt) 
homology (Allende et al., 1999; Collins et al., 1992; Meulenberg et al., 1993; Nelsen et 
al., 1999). Although distinct genetically and antigenically, both types exhibit the same 
genome organization and nearly the same pathogenesis. PRRSV is an enveloped, 
single-stranded, positive-sense RNA virus classifying in the Arteriviridae family 
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within the genus Arterivirus, along with equine arteritis virus (EAV), lactate 
dehydrogenase-elevating virus (LDV) of mice, and simian hemorrhagic fever virus 
(SHFV), because of their similar morphology, genome organization, transcription 
strategy, macrophage tropism, the ability to induce prolonged viremia and persistent 
infections (Benfield et al., 1992; Cavanagh, 1997; Plagemann and Moennig, 1992). 
The family Arteriviridae, Toroviridae, and Coronaviridae are the members of a single 
established order, Nidovirales (Cavanagh, 1997) (Figure 1). 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
Figure 1. Nidovirales order classification (Cavanagh, 1997) 
 
 
3.2. Viral genomic organization 
 
As described in the earlier studies, mature PRRSV virions contain a spherical 
icosahedral capsid core of 20-30 nm in diameter, which is surrounded by a lipid 
envelope containing the viral membrane proteins, yielding a relatively smooth 
spherical virion of about 60 nm in diameter (Benfield et al., 1992; Dea et al., 2000; 
Doan and Dokland, 2003a; Doan and Dokland, 2003b). Recently, Spilman et al. 
(Spilman et al., 2009) described the structure of PRRSV virions based on cryo-electron 
microscopy (EM) analysis and tomographic reconstruction of virions grown in 
MARC-145 cells. They reported that the virus has a pleomorphic morphology, a 
Species
Family 
Order 
Genus
PRRSV SHFV  LDVEAV  
Nidovirales
Coronaviridae 
Coronavirus 
Arteriviridae Roniviridae 
Torovirus Arterivirus Okavirus
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spherical to oval shape with a size ranging from about 50 to 65 nm, a hollow, layered 
core of around 40 nm diameter and a smooth outer surface studded with a few 
envelope protein complexes. The structural analysis indicated that the PRRSV core 
consists of an helical nucleocapsid wrapped up into a hollow ball (Spilman et al., 
2009), contrary to previous studies (Benfield et al., 1992; Dea et al., 2000; Doan and 
Dokland, 2003a; Doan and Dokland, 2003b). These results were not surprising since 
other members of the Nidovirales, such as Coronavirus, are known to possess a 
helicoidal capsid (Figure 2). The 5’-capped and 3’-polyadenylated viral genome is 
approximately 15 kb in length (Meulenberg et al., 1993; Snijder and Meulenberg, 
1998; Wootton et al., 2000). The viral genome contains nine known overlapping open 
reading frames (ORFs), designated ORF1a, ORF1b, ORF2a, ORF2b, and ORFs3 
through 7(from the 5’ to 3’end of the genome), which are transcribed into a nested set 
of subgenomic mRNAs (sg mRNAs) as shown in Figure 3 (Dea et al., 2000; 
Meulenberg et al., 1993; Wootton et al., 2000; Wu et al., 2001). The replicase-
associated genes which occupy approximately 75% of the viral genome, ORF1a and 
ORF1b, code for polyproteins pp1a and pp1ab by ribosomal frame shifting, and these 
proteins are directly translated from the incoming genomic viral RNAs (Snijder and 
Meulenberg, 1998). The pp1a is predicted to be cleaved at eight sites to form nine 
nonstructural proteins (nsp): nsp1α, nsp1β, and nsp2 to nsp8 (den Boon et al., 1995; 
Snijder and Meulenberg, 1998). Proteolytic cleavage of the ORF1b portion of the 
pp1ab generates products of nsp9 through nsp12 (van Dinten et al., 1996). The 13 
nonstructural proteins (nsp) are believed to be involved in genome replication and 
transcription (Bautista et al., 2002; van Dinten et al., 1999). The C-terminus of ORF1a 
overlaps the N-terminus of ORF1b by 16 nucleotides. A heptanucleotide slippery 
sequence, UUUAAAC, located just upstream of the UAG stop codon of ORF1a, and a 
pseudo-knot structure downstream of the slippery sequence is believed to be essential 
for the expression of ORF1b of PRRSV via a mechanism of ribosomal frame-shifting 
(Allende et al., 1999; Meulenberg et al., 1993; Nelsen et al., 1999). The 3’ end of the 
genome (ORFs2 through 7) encodes four glycosylated membrane associated proteins 
GP2a, GP3, GP4, GP5 (encoded by sg mRNAs 2a, 3-5), two unglycosylated 
membrane proteins E and M (encoded by sg mRNAs 2b and 6), and a nucleocapsid 
protein (N) (encoded by sg mRNA 7) (Table 1) (Bautista et al., 1996; Mardassi et al., 
1996; Meng et al., 1995a; Meulenberg and Petersen-den Besten, 1996; Meulenberg et 
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al., 1995; Mounir et al., 1995; Snijder and Meulenberg, 1998; Wu et al., 2001; Wu et 
al., 2005). Three N-glycosylated minor envelope proteins (GP2a, GP3, and GP4) form 
heterotrimers by disulfide linkage (Wissink et al., 2005). The nature of GP3 is still 
controversial, as there are conflicting data regarding its presence as a constituent of the 
envelope of virus particles. It has been convincingly demonstrated that GP3 is a 45- to 
50-kDa structural protein of the PRRSV LV (type I or European) strain (van 
Nieuwstadt et al., 1996). However, the GP3 has been reported as being a non-structural 
protein of the PRRSV type II IAF-Klop strain, with a subset of viral GP3 being 
released into the cell culture medium as a non-virion associated and membrane-free 
form (Gonin et al., 1998; Mardassi et al., 1998). In the recent years, accumulated data 
have suggested that GP3 is a structural protein of the PRRSV NA type (Cancel-Tirado 
et al., 2004; Jiang et al., 2008). Most recently, it was reported that GP3 is a minor 
structural component of the PRRSV type II (FL12 strain) virion, similar to what has 
been previously described for PRRSV type I (de Lima et al., 2009).  The N protein is 
not N-glycosylated, although it contains 1 or 2 potential N-glycosylation sites 
(Meulenberg et al., 1995). All structural proteins are translated from a nested set of 3’-
coterminal subgenomic mRNAs, which contain a common leader sequence 
(Meulenberg et al., 1995; Snijder and Meulenberg, 1998; Wu et al., 2001).  
 
Table I. Comparison of ORFs2 to 7 encoded protein between NA and EU strains of 
PRRSV 
Coding  
gene  
proteins No. of aa 
residues 
Predicted 
Mr(kDa) 
Apparent 
Mr(kDa) 
N-Glycosylation  
used sites 
EU NA EU NA EU NA EU NA 
ORF2a GP2a 249 256 28.4 29.5 29-30 27-29 2 2 
ORF2b E 70 73 7.8 8.2 10 10 0 0 
ORF3 GP3 265 254 30.6 29.0 45–50 42–45 7 7 
ORF4 GP4 183 178 20.0 19.6 31–35 31–35 4 4 
ORF5 GP5 201 200 22.4 22.4 25 24-26 2 2–5 
ORF6 M 173 174 18.9 19.1 18 19 0 0 
ORF7 N 128 123 13.8 13.6 15 14-15 0 0 
Adapted from Dea S., et al., 2000 with some modifications (Wu et al., 2001). EU: European strains, NA: North American strains, 
E protein was previously called GP2b 
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GP5 + M
Heterodimer
(Dea et al., 2000; Delpute et al., 2002; Snijder et al., 2003)
GP3 : virion structural natur is controversal:
a) Incorporated into virions (Meulenberg et al., 1995), membrane-associated as 
heterotrimers with GP2a and GP4 (Wissink et al., 2005); a minor structural 
component of the PRRSV type II (FL12 strain) virion (de Lima, et al 2009)
b)     nonstructural and secreted from PRRSV infected cells (IAF-Klop strain)
(Mardassi et al., 1998) 
E + GP2a-GP3-GP4
Heterotrimer and/or heteromultimeric complex
(Wieringa et al., 2004; Wissink et al., 2005)
GP3
GP5
M
GP4
GP2a
N
E
ssRNA
 
Figure 2. Schematic representation of the virion of PRRSV. The virion is spherical to 
oval in shape, enveloped, and possesses a non-segmented single-strand RNA genome 
that is encapsidated by the nucleocapsid protein (N), yielding a helicoidal capsid 
structure. (Kindly provided by Nedzad Music with modifications). 
 
 
 
Figure 3.  PRRSV genomic organizations (Dea et al., 2000; Meulenberg et al., 1993; 
Wootton et al., 2000; Wu et al., 2001).  
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3.3. Virus biological and physical properties 
 
Being an enveloped virus, infectivity of PRRSV outside of the host is affected 
by temperature, pH and exposure to detergents. It has been reported that infectivity of 
PRRSV was unchanged after 1 month incubation at 4oC or 4 months at -70oC 
(Benfield et al., 1992). However, the infectivity decreases with increasing temperature. 
Specifically, infectivity was reduced 50% after incubation for 12 hours at 37oC and 
was completely inactivated after 48 hours of incubation at 37oC and 45 minutes 
incubation at 56oC (Benfield et al., 1992). The PRRSV remains stable at pHs ranging 
from 6.5 to 7.5 (Bloemraad et al., 1994). Detergents are effective at reducing 
infectivity of the virus and lipid solvents such as chloroform and ether are particularly 
efficient at disrupting the viral envelope and inactivating the virion (Benfield et al., 
1992). The virus survives in water for up to 11 days, but drying quickly inactivates it 
(Benfield et al., 1999). Buoyant densities of the infectious viral particles are 1.13–1.15 
g/ml in sucrose and 1.18–1.19 g/ml in CsCl (Benfield et al., 1992; Mardassi et al., 
1994a; Wensvoort, 1993). 
 
3.4. Virus genetic variation 
 
As for other envelope RNA viruses, a high degree of genomic variability has 
been reported for the Arterivirus (Snijder and Meulenberg, 1998), including PRRSV 
(Mardassi et al., 1994b; Meng et al., 1995a; Meng et al., 1995b; Murtaugh et al., 1995; 
Nelsen et al., 1999). Sequence comparisons have shown that there are significant 
genetic differences between the prototype strains from North America (ATCC VR-
2332) and Europe (Lelystad virus - LV) (Meulenberg et al., 1993; Murtaugh et al., 
1995; Nelsen et al., 1999), which share only about 63% nucleotide identity (Allende et 
al., 1999; Nelsen et al., 1999). At the beginning of the global PRRSV epidemic, EU 
types were detected only in Europe, while US types were restricted to North and 
Central America (Andreyev et al., 1997) and Asia (Shibata et al., 1996). Now, EU type 
PRRSV has been found in the US (Fang et al., 2004; Ropp et al., 2004), while US type 
has been introduced to Europe through the use of a live vaccine (Botner et al., 1999; 
Botner et al., 1997; Nielsen et al., 2001; Nielsen et al., 2002; Storgaard et al., 1999). 
Until now, the EU type strain has never been reported in the field in Canada.  
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phylogenetic analysis places the most recent common ancestor (MRCA) for the EU 
and US genotypes at at least 100 years back in time (Forsberg, 2005; Hanada et al., 
2005; Stadejek et al., 2002), providing strong support for the hypothesis that EU and 
US viruses evolved in parallel in North America and Europe prior to their cotemporal 
species jump into pigs and emergence as clinical entities in the later 1980s. Originally, 
EU genotype viruses were thought to form a very homogeneous, ‘Lelystad-like’ group 
(Drew et al., 1997; Le Gall et al., 1998; Suarez et al., 1996b; Wensvoort et al., 1991b). 
Recently, the view that EU genotype viruses are genetically homogeneous was 
challenged by the studies of unusually diverse EU genotype PRRSV strains, first in 
Denmark (Oleksiewicz et al., 2000) and later in Italy (Forsberg et al., 2002), the Czech 
Republic (Indik et al., 2000), Poland (Stadejek et al., 2002), Spain (Mateu et al., 2003), 
Germany and the Netherlands (Pesch et al., 2005) and even Thailand 
(Thanawongnuwech et al., 2004a). 
 Genetic analyses have shown the existence of two major virus genotypes, the 
EU and the NA, with extensive genetic variability both within and between these 
genotypes. The leader sequence of PRRSV strains varies significantly. The 190 bp 
leader sequence of ATCC VR-2332 strain is 31 bp shorter than that of LV, and 
possesses a sequence identity of 61% with LV (Nelsen et al., 1999). The leader 
sequence of another NA strain, the 16244B strain, is 189 bp in length and also differs 
considerably in nucleotide sequence compared to LV (Allende et al., 1999). Like the 
leader sequence, the ORF1 gene sequence also differs extensively between the U.S. 
and the European strains (Allende et al., 1999; Nelsen et al., 1999). The ORF1a of 
ATCC VR-2332 strain shares only about 55% nucleotide sequence identity when 
compared to LV. ORF1b is more conserved than ORF1a and shares about 63% 
nucleotide sequence identity compared to LV.  
Marked differences were also found between EU and NA isolates in some 
structural genes (Kapur et al., 1996; Murtaugh et al., 1995). GP5 is the most variable 
structural protein (Mardassi et al., 1995; Meng et al., 1995b) with the highest degree of 
diversity within one genotype. Among NA isolates, nucleotide homology of the GP5 
coding region was found to be 90% or even less (Andreyev et al., 1997; Dee et al., 
2001; Meng, 2000) and from 51 to 59% when NA viruses are compared to LV virus 
(Andreyev et al., 1997; Kapur et al., 1996; Meng et al., 1994; Murtaugh et al., 1995). 
N protein encoding region (ORF7) is highly conserved among NA isolates, with 95 to 
100% amino acid homology, but a comparison of NA viruses and LV revealed only 57 
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to 59% amino acid homology (Meng et al., 1995a; Murtaugh et al., 1995). M (Matrix) 
protein encoding region (ORF6) is the most conserved gene among NA isolates, with 
96% to 100% amino acid (aa) identity, and is the most conserved gene between NA 
and EU isolates, with 70 to 81% identity (Kapur et al., 1996; Meng et al., 1995b; 
Murtaugh et al., 1995).  
Based on sequence analysis, the degree of aa identity amongst the NA PRRSV 
isolates varied from 91 to 99% for GP2 (GP2a and E), 86 to 98% for GP3, and 92 to 
99% for GP4 (Kapur et al., 1996; Mardassi et al., 1995; Meng et al., 1995b; Morozov 
et al., 1995). A comparison of LV with isolate ATCC VR-2332 revealed aa identities 
of 63, 76, 58, and 68% for GP2a, E, 3, and 4, (Murtaugh et al., 1995; Ropp et al., 
2004). With approximately 54 to 60% aa identity between the NA and EU isolates of 
PRRSV, GP3 is regarded as the second most variable protein amongst PRRSV strains 
(Mardassi et al., 1995; Murtaugh et al., 1995), with most of the variations located at 
the N-terminus. In fact, only 29% aa identity is found within the 35 most N-terminal 
residues between strains from the two continents. Interestingly, despite these extensive 
aa changes, the potential N-linked glycosylation sites, as well as the general 
hydropathy profiles of the ORF3 product, are highly conserved. In addition, the GP3 of 
the NA strains have a C-terminal deletion of 12 aa compared to LV (Mardassi et al., 
1995; Meng et al., 1995b; Morozov et al., 1995). According to a study using UK 
PRRSV isolates, the ORF3 product has a hydrophilic hypervariable region proximate 
to the C-terminal region that overlaps with ORF4, resulting in a hypervariable region 
located at the N-terminal extremity of GP4 (Drew et al., 1997; Katz et al., 1995).  
 
4. Pathogenesis 
 
4.1. Virus entry into susceptible cells 
 
PRRSV cell interactions and how the virus enters the cells were first reported 
in 1996 (Kreutz and Ackermann, 1996). It was speculated that since the direct fusion 
of the PRRSV envelope with the cellular membrane was not observed at any time, 
PRRSV entry most probably occurs by receptor-mediated endocytosis. In 1998, this 
hypothesis was confirmed (Duan et al., 1998) and a PRRSV receptor was identified on 
PAM by generation of PAM-specific monoclonal antibodies. Now it is generally 
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believed that despite the very restricted cell tropism of PRRSV, the virus is able to 
replicate in several non-permissive cell lines upon transfection of its viral RNA. Cell 
tropism is determined by the presence or absence of specific receptors on the cell 
surface or other proteins involved in virus entry (Kreutz, 1998; Meulenberg et al., 
1998).  
So far, several viral receptor candidates or viral binding proteins for PRRSV 
have been described, including heparan sulphate for binding and sialoadhesin (CD169) 
for internalization on macrophages, binding protein vimentin on MARC-145, CD163 
on MARC-145 and PAMs and CD151 on MARC-145 (Calvert et al., 2007; Delputte et 
al., 2002; Kim et al., 2006; Kristiansen et al., 2001; Shanmukhappa et al., 2007; 
Vanderheijden et al., 2001; Vanderheijden et al., 2003). In addition, a yet unidentified 
150 kDa polypeptide doublet and a 210 or 220 kDa glycoprotein, which can be 
speculated to be sialoadhesin, were found to be involved in PRRSV infection of 
macrophages (Duan et al., 1998; Wissink et al., 2003). In the current model for 
PRRSV infection of macrophages, heparan sulfate serves as an attachment factor that 
binds to viral structural M protein or the M-GP5 complex but is not required for 
internalization (Delputte et al., 2005; Delputte et al., 2002). Subsequently, PRRSV will 
engage sialoadhesin in a more stable interaction involving sialic acids present on the 
virion and the N-terminal sialic acid-binging domain of sialoadhesin, followed by 
internalization (Delputte et al., 2005; Delputte et al., 2004; Delputte and Nauwynck, 
2004; Delputte et al., 2007b; Gorp et al., 2008). Upon internalization, the virus is 
transported towards an endosomal compartment where a drop in pH is required for 
proper virus replication (Kreutz and Ackermann, 1996; Nauwynck et al., 1999). 
The CD163, a cellular protein in the scavenger receptor cystein rich (SRCR) 
super family and a type I membrane glycoprotein, has been described functioning as 
the macrophage receptor for hemoglobin-haptoglobin complex binding and as a 
cellular receptor for PRRSV infection (Calvert et al., 2007; Kristiansen et al., 2001) . 
CD163 was also essential in PRRSV infection of MARC-145 cells and rendered many 
non-permissive cells susceptible to PRRSV infection upon expression (Calvert et al., 
2007). Moreover, a more recent research demonstrated that co-expression of 
recombinant CD163 and sialoadhesin in non-permissive cells increased virus 
production 10-100 times compared with cells expressing only CD163, sustaining the 
requirement of both molecules for efficient PRRSV infection (Gorp et al., 2008).  
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The CD151 molecule was identified by RNA-ligand screening of a MARC-145 
cell expression library to be a PRRSV 3' UTR RNA-binding protein (Shanmukhappa 
et al., 2007). In several RNA viruses, the interaction between 5’ and/or 3’ UTR RNA 
and host cell proteins was already reported to play an important role in virus 
replication mechanisms, such as the transcription, translation, orientation and transport 
of viral RNA (Loffler et al., 1997; Yu and Leibowitz, 1995). The CD151 is a member 
of the tetraspanin superfamily, which has several cellular functions that include cell 
signaling, cell activation and platelet aggregation (Fitter et al., 1999; Hasegawa et al., 
1998; Sincock et al., 1999). Transfection of CD151 rendered BHK-21, a non-
susceptible cell line, susceptible to PRRSV infection. The transfection of siRNA 
against CD151 inhibited PRRSV infection into MARC-145 cells. Additionally, 
polyclonal anti-CD151 antibody (Ab) completely blocked PRRSV infection into 
MARC-145 cells (Shanmukhappa et al., 2007). These results suggest that CD151 plays 
a critical role in PRRSV infection in vitro. Since CD151 is a transmembrane protein, it 
is reasoned that this molecule serves as the entry molecule (Shanmukhappa et al., 
2007). 
 
4.2. Virus transmission 
 
It is known that one of the main characteristics of PRRSV is its high 
transmissibility, which almost certainly contributed markedly to its quick spread 
around the world. Pigs are susceptible to infection by a number of routes, including 
oral, intranasal, intramuscular, intraperitoneal, and vaginal routes (Rossow et al., 1994) 
(Figure 4).  
It is well documented that PRRSV can be transmitted by direct contact, through 
close ‘snout to snout’ contact between pigs or by contact with organic secretions 
excreted by infected pigs (Christopher-Hennings et al., 1995; Rossow et al., 1994; 
Wills et al., 1997a; Wills et al., 1997b; Yoon et al., 1993). In addition, there seems to 
exist various other indirect ways by which PRRSV can disseminate to a susceptible 
population, including contaminated fomites (Otake et al., 2002b; Otake et al., 2002c), 
arthropods (Otake et al., 2002d; Otake et al., 2003) and aerosols (Otake et al., 2002a). 
A. Direct transmissions 
The PRRSV has been recovered from a variety of porcine secretions and 
excretions including semen, saliva, feces, and milk and colostrum (Rossow et al., 
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1994; Swenson et al., 1994; Wagstrom et al., 2001; Wills et al., 1997b; Yoon et al., 
1993). Specifically, infectious PRRSV and PRRSV RNA have been detected in the 
semen of experimentally infected boars up to 43 and 92 days post-infection, 
respectively (Christopher-Hennings et al., 1995; Swenson et al., 1994). Fecal shedding 
remains a highly debated issue; several studies report the presence of PRRSV in feces 
from 28 to 35 days following experimental infection whereas others report no 
detection of virus in fecal samples (Wills et al., 1997b; Yoon et al., 1993). 
B. Indirect transmissions 
Several indirect transmissions by fomites have been identified. Specifically, 
boots and coveralls have been identified as potential sources of PRRSV transmission 
to naïve pigs (Otake et al., 2002c). Due to the propensity for PRRSV replication and 
circulation in the bloodstream, needles have also been recognized as an indirect means 
of PRRSV transmission between pigs, demonstrating the need for proper needle 
management (Otake et al., 2003). Mechanical transmission of PRRSV was 
demonstrated throughout a coordinated sequence of events involving fomites (boots, 
coolers and containers, shipping parcels, vehicles) (Dee et al., 2003; Dee et al., 2002). 
However, studies have demonstrated that certain intervention strategies, such as the 
use of disposable footwear, boot baths, the wearing of gloves and double-bagging 
products designated for entry into farms significantly reduced the level of PRRSV 
contamination on the surface of objects and mechanical spread of the virus (Dee et al., 
2004). 
Even if PRRSV is relatively fragile in the environment, appropriate weather 
(wind, temperature, humidity etc) may favour the transmission of the virus trough 
aerosols up to 4.7 km distance (Dee et al., 2009) . 
Insects (mosquitoes (Aedes vexans) and houseflies (Musca domestica)) are 
commonly observed in swine facilities during the summer months and have been 
shown to mechanically transmit PRRSV from infected to naïve pigs under 
experimental conditions (Otake et al., 2002d; Otake et al., 2003). Transport of PRRSV 
by insects throughout an agricultural area has been reported for up to 2.4 km following 
contact with an infected pig population (Schurrer et al., 2004). However, the 
significance of these vectors under field conditions, i.e. in commercial pig farms, still 
needs to be determined. 
Previous studies investigated the role of various mammals (rodents, raccoons, 
dogs, cats, opossums, skunks) and birds (house sparrows and starlings) in the 
 
 18
transmission of PRRSV(Wills et al., 2000b); none were capable of serving as 
mechanical or biological vectors (Wills et al., 2000b). 
 
 
 
Figure 4.  Pathogenesis of PRRSV infection (adapted from www.porcilis-prrs.com) 
 
 
4.3. PRRSV cell and tissue tropism 
 
PRRSV is generally believed to have a very restricted cell tropism both in vivo 
and in vitro. In vivo, the virus mainly infects well-differentiated cells of the monocyte-
macrophage lineage, in particular porcine alveolar macrophages (PAM), the primary 
target cells of virus and interstitial macrophages in other tissues such as heart, thymus, 
spleen and Peyer's patches, hepatic sinusoids, renal medullary interstitium, and adrenal 
gland (Beyer et al., 2000; Duan et al., 1997; Halbur et al., 1996a; Halbur et al., 1995b). 
In addition to macrophages, PRRSV RNA and nucleocapsid protein were found by in 
situ hybridization (ISH) in testicular germ cells, endothelial cells in the heart, 
interdigitating cells in the thymus, dendritic cells in the spleen and Peyer's patches 
(Halbur et al., 1996a; Sur et al., 1997). In experimentally infected gnotobiotic pigs, 
PRRSV antigen were found in bronchiolar epithelial cells, arteriolar endothelial cells, 
monocytes as well as interstitial, alveolar, and intravascular macrophages using an 
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immnogold-silver immunohistochemical staining (Rossow et al., 1996). The antigens 
and RNA of European, North American and Korean strains of PRRSV were found in 
bronchiolar epithelial cells (Pol et al., 1991), epithelium-like cells of alveolar ducts 
(Magar et al., 1993), and pneumocytes (Cheon et al., 1997; Pol et al., 1991) in the 
naturally infected pigs, whereas they were not found in these types of cells in the 
experimentally infected pigs (Teifke et al., 2001). Tissues such as lung, lymphoid 
tissues, Peyer’s patches, and kidney were also the preferred organ targets of PRRSV 
infection (Haynes et al., 1997; Sur et al., 1996). Studies showed that PRRSV 
distribution was also isolate or strain-dependent, for instance, more virulent strains had 
more positive PRRSV cell distribution in more tissues and organs (Haynes et al., 
1997). It has been reported that PRRSV can be isolated from the ovary and may be 
responsible for episodes of female reproductive failure, and PRRSV antigens & RNAs 
were detected in ovarian follicles in gilts as well (Collins et al., 1992; Kranker et al., 
1998; Prieto et al., 1996; Prieto et al., 1997a; Prieto et al., 1997b; Prieto, 1996; Sur et 
al., 2001).  
In vitro, PRRSV can grow in a few cell lines. So far, primary cultures of PAMs 
as well as freshly isolated blood monocytes or monocytic derived dendritic cells 
(Voicu et al., 1994; Wang et al., 2007; Wensvoort et al., 1991b) are known to be the 
only porcine cells that can effectively be used for viral growth. Other non-porcine 
permissive immortalized cell lines that permit the complete replication cycle of 
PRRSV are African green monkey kidney cells or derivatives thereof such as MARC-
145 or CL2621 (Bautista et al., 1993; Benfield et al., 1992; Kim et al., 1993). 
 
4.4. PRRSV-induced apoptosis 
 
Apoptosis, necrosis/oncosis, autophagy and pyroptosis are now generally 
recognized distinct processes leading to eukaryotic cell death, with clearly 
distinguishable morphological and biochemical features (Bergsbaken et al., 2009; Fink 
and Cookson, 2007; Labbe and Saleh, 2008; Wyllie et al., 1980). However, apoptosis 
and necrosis/oncosis are better-recognized molecular mechanisms of eukaryotic cell 
death and can simultaneously occur in tissue or cells exposed to the same stimuli 
(Shimizu et al., 1996). Whether a cell undergoes apoptosis or not depends on a delicate 
balance of anti- and pro-apoptotic stimuli (Costers et al., 2008). Mechanistically, 
apoptosis results from the activity of a distinct subset of caspases (cysteine-dependent 
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aspartate-specific proteases). Initiator caspases are activated primarily by two 
mechanisms (Green, 2003): 1) ligation of cell surface death receptors, including the 
tumor necrosis factor-alpha (TNF-α) receptor and Fas, leads to caspase-8 activation 
via the extrinsic pathway, and 2) mitochondrial release of cytochrome c activates 
caspase-9 via the intrinsic pathway. The pathways cross-talk, as caspase-8 can promote 
cytochrome C release and caspase-9 activation. Both caspase-8 and caspase- 9 activate 
executioner caspases, including caspase-3, which cleave cellular substrates to produce 
the features associated with apoptosis. These characteristics include cytoplasmic and 
nuclear condensation, oligonucleosomal DNA cleavage and maintenance of an intact 
plasma membrane. Apoptotic cells package their contents into membrane-bound 
apoptotic bodies and expose surface molecules like phosphatidylserine to target 
phagocytic uptake and removal such that apoptosis is generally non-inflammatory in 
vivo (Elmore, 2007; Fink and Cookson, 2007). Apoptosis is considered to be an 
important host defense mechanism that interrupts viral replication and eliminates 
virus-infected cells (Thomson, 2001). Apoptosis can be induced in virus-infected cells 
by host immune cells, such as cytotoxic T-lymphocytes and natural killer cells through 
soluble factors or through direct cell-to-cell contact. In addition, apoptosis can be 
induced in virus-infected cells as a response to viral replication (Matsumoto et al., 
2005; Tanaka et al., 1998). Induction of apoptosis before completion of viral 
replication would severely limit progeny virus production and virus spread in the host. 
Consequently, viruses have evolved strategies that inhibit apoptosis during replication, 
thereby ensuring cell survival until sufficient virus progeny is produced (Teodoro and 
Branton, 1997; Thomson, 2001). Many viruses have adapted by encoding anti-
apoptotic gene products that permit their seemingly undetected replication. Some 
viruses (e.g., African Swine Fever Virus, ASFV) encode proteins that prevent 
apoptosis through inactivation of p53 or binding of Bax (Afonso et al., 1996; Brun et 
al., 1996; Neilan et al., 1993; Revilla et al., 1997; Young et al., 1997). Yet other 
viruses (such as Baculovirus) possess mechanisms to inhibit apoptosis by expressing 
caspase inhibitors that interfere with caspase function (Manji and Friesen, 2001). Thus, 
viruses have evolved numerous mechanisms acting at many different targets to 
interfere and block apoptosis. 
Several studies demonstrated that PRRSV infection induced apoptosis both in 
vitro and in vivo (Choi and Chae, 2002; Kim et al., 2002; Labarque et al., 2003; Miller 
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and Fox, 2004; Sirinarumitr et al., 1998; Suarez et al., 1996a; Sur et al., 1997; Sur et 
al., 1998). PRRSV infection of MARC-145 and porcine alveolar macrophages (PAMs) 
resulted in apoptosis characterized by morphological changes, DNA fragmentation and 
specific caspase activation. PRRSV induces apoptosis both directly (in infected cells) 
and indirectly (in bystander cells) and within both infected tissue cultured cells and 
animals, apoptotic cells are observed and contribute to the pathology observed in the 
animal (Sirinarumitr et al., 1998).  
The evidence of direct induction of apoptosis coming from in vitro studies 
demonstrated that artificial expression of GP5 using viral vectors can induce apoptosis 
within cell monolayers, but the mechanism was not well elucidated (Gagnon et al., 
2003; Suarez et al., 1996a). Expression of PRRSV GP5 (ORF5) gene in cell 
monolayers using a vaccinia virus expression vector induced apoptosis, while the 
vaccinia vector alone did not (Suarez et al., 1996a). Gagnon et al. (2003) expressed the 
GP5 protein using an adenovirus expression system and detected an increase in 
caspase 3 activity in cell monolayers transfected with recombinant vector (Gagnon et 
al., 2003). The apoptosis inducing region of GP5 has been mapped to the N-terminal 
119 amino acids by Fernandez et al. (Fernandez et al., 2002). Recently, the question of  
if and when PRRSV modulates apoptosis in PRRSV-infected macrophages was 
investigated (Costers et al., 2008). This study showed that during a PRRSV infection 
two oppositely directed sets of reactions are switched on in PRRSV-infected 
macrophages in vitro: at first, reaction favor anti-apoptosis, but finally, PRRSV-
infected macrophages die by apoptosis (Costers et al., 2008). Both anti- and pro-
apoptotic effects were not only observed in PRRSV-infected macrophages, but also in 
PRRSV-infected MARC-145 cells (Costers et al., 2008). In conclusion, this study 
showed that PRRSV replication results in activation of anti- and pro-apoptotic 
pathways. Early in infection, the balance tends towards anti-apoptosis, whereas late in 
infection, the balance is driven towards pro-apoptosis. In addition, this study indicates 
that the ability of PRRSV to modulate apoptosis in the infected cell is intrinsic to the 
virus, and not dependent on the cell type (Costers et al., 2008). Lee et al. (2007) 
provided further evidence of apoptosis induced by PRRSV directly in PRRSV-infected 
MARC-145 cells and ultimately, the authors elucidated that PRRSV induced apoptosis 
is through a mitochondria-mediated pathway. In summary, these authors demonstrated 
that (i) PRRSV infection causes characteristic morphological and biochemical changes 
of apoptosis such as chromatin condensation, DNA fragmentation, externalization of 
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phosphatidylserine (PS), caspase activation, and poly (ADP-ribose) polymerase 
(PARP) cleavage; (ii) PRRSV induces caspase-dependent apoptosis and activates both 
caspase-8 and caspase-9; (iii) a crosstalk between extrinsic and intrinsic pathways 
existed since caspase-8 activated through ligation of the death ligand with the death 
receptor, possibly TNFR-α/TNFR1 and Fas/FasL, and mediates caspase-9 activation 
via Bid cleavage; (iv) PRRSV caused an increased ratio of Bax/Bcl-2 which is 
followed by the disruption of the mitochondrial transmembrane potential and 
cytochrome c release; (v) oxidative stress induced by PRRSV is involved in apoptosis; 
and (vi) PRRSV infection causes secondary necrosis (Lee and Kleiboeker, 2007). 
Other studies have shown that PRRSV induces apoptosis mostly in uninfected 
bystander cells both in vitro and in vivo. In previous studies, the majority of apoptotic 
cells were detected in lung lavages, lungs, and lymphoid tissues by using IHC, 
TUNEL, DNA electrophoresis, and electron microscopy, but upon performing dual-
labeling experiments it was concluded that the majority of apoptotic cells were not 
infected with PRRSV (Choi and Chae, 2002; Kim et al., 2002; Labarque et al., 2003; 
Miller and Fox, 2004; Sirinarumitr et al., 1998; Suarez et al., 1996a; Sur et al., 1997; 
Sur et al., 1998). Chang and collaborators have reported that alveolar macrophages 
from PRRSV-infected pigs showed a significantly increased apoptotic rate (22-34%) 
compared to porcine circovirus 2 infected alveolar macrophages (3%) (Chang et al., 
2005). Given the fact that only 5-10% of alveolar macrophages were PRRSV-infected, 
theses authors suggested that TNF-α or GP5 released from PRRSV-infected cells 
caused apoptosis in bystander cells. Another study from the same group demonstrated 
that increased FasL expression in PRRSV-infected macrophages caused apoptosis in 
co-cultured swine splenic lymphocytes (Chang et al., 2007). 
 
5. Host immunology 
 
A complex immunological interaction exists between PRRSV and pigs that 
involves both induction and subversion of host defenses (Murtaugh et al., 2002). 
Immunization to PRRSV infection is a double-edged sword. On the one hand, PRRSV 
has a predilection for immune cells and the disease manifestations can be linked 
directly to changes in the immune system. PRRSV appears to replicate exclusively in 
cells of the immune lineage, notably macrophages; the direct replication of which may 
 
 23
lead to immunosuppression, precipitate secondary infection and/or mediate disease. On 
the other hand, the virus stimulates immunity post-infection that protects an animal 
from re-infection. Thus, the immune system appears to be intimately involved in both 
the disease process and protection from disease (Molitor et al., 1997). PRRS is one of 
the most challenging subjects of research in veterinary viral immunology and our 
current knowledge on the basic mechanisms for PRRSV protective immunity is still 
fragmentary.  
Because porcine alveolar macrophages (PAMs) have a pivotal role for an 
effective innate and adaptive immune response (Janeway et al., 2005a; Janeway et al., 
2005b), any suppression of macrophage function plus a fall in macrophage numbers 
due to viral infection could increase the host’s susceptibility to secondary infections. 
For the innate immune response, the main role of PAMs is to ingest and subsequently 
kill pathogens, and release cytokines such as TNTα and IL-1, which can activate 
pathways of both the innate and adaptive immune response (Fearon and Locksley, 
1996; Janeway et al., 2005a; Janeway et al., 2005b). By acting as antigen-presenting 
cells, macrophages, along with dendritic cells (DCs), also trigger the adaptive immune 
response (Janeway et al., 2005a). PRRSV can also multiply inside DCs, which can 
affect the activation of these cells and prevent triggering of the adaptive immune 
response (Loving et al., 2007; Wang et al., 2007). Several studies have also shown 
weak and atypical innate immune responses, such as weak IFN-α responses (van 
Reeth, 1999) and high induction of interleukin(IL)-10 in PRRSV-infected porcine 
monocytes, macrophages and dendritic cell (Flores-Mendoza et al., 2008; Suradhat et 
al., 2003) and in vivo in PRRSV-infected pigs (Suradhat, 2003; Sutherland et al., 2007; 
Thanawongnuwech et al., 2004a; Thanawongnuwech et al., 2004b)  
Pigs mount a rapid antibody response to infection by PRRSV, which is 
detectable from day 5 post-infection, but these early antibodies are mainly directed to 
the N- and M-proteins and are non-neutralizing. Neutralizing antibodies (NAbs) begin 
to appear between 7-28 days post-infection, but their titers remain low, and substantial 
variation in the neutralizing antibody response has been reported (Loemba et al., 1996; 
Plagemann, 2006). Typical titers of serum NAbs, which are considered unusually low 
in comparison with those induced by other viruses, are between 2 and 12 (Labarque et 
al., 2000; Loemba et al., 1996). Thus the humoral immune response to PRRSV in pigs 
is characterized by early production of strong, non-NAbs, which are detected from 5-6 
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days post-infection (pi), followed by the delayed appearance of neutralizing antibodies 
between 3 and 4 weeks post-infection, which then persist at low levels (Figure 5) 
(Lopez and Osorio, 2004).   
The protective capacity of NAbs is debated. The early development of non-
NAbs and later development of NAbs may have a significant effect on the 
development of PRRSV persistent infections. It has been shown that non-NAbs 
enhance viral replication in alveolar macrophages, a phenomenon known as antibody-
dependent enhancement (ADE) (Yoon et al., 1996; Yoon et al., 1997). The non-
neutralizing humoral response may act as a Trojan horse for PRRSV by coating the 
virus and enhancing the internalization of viral particles into macrophages (Mateu and 
Diaz, 2008). In contrast, development of NAbs is not sufficient to completely 
eliminate the virus (Mateu and Diaz, 2008). Likewise, viremia may be resolved in the 
absence of detectable levels of neutralizing antibodies (Diaz et al., 2006). Nonetheless, 
NAbs may play a central role in protecting swine against reinfection with PRRSV 
since passive transfer of antibodies fully protected pregnant sows against a challenge 
of virulent PRRSV and blocked transplacental infection (Osorio et al., 2002). 
Similarly, pigs receiving an amount of NAbs sufficient to reach a serum titer of 8 
consistently did not develop viremia, whereas serum titers of 32 produced sterilizing 
immunity (Lopez and Osorio, 2004; Osorio et al., 2002). However, other authors do 
not report such a strong correlation between NAbs and the absence of viremia (Jiang et 
al., 2007a; Jiang et al., 2007b; Jiang et al., 2007c; Plagemann, 2006; Zuckermann et 
al., 2007). Delay in the neutralizing antibody response to PRRSV has been postulated 
(in addition to other hypotheses) to be due to the presence of a nearby 
immunodominant “decoy” epitope (aa 27–30 of GP5), which may evoke a robust, 
early, and non-protective immune response that masks and/or impairs the response to 
the major neutralizing epitope (aa 37-45 of GP5) (Ostrowski et al., 2002).  An 
alternative explanation of the peculiar nature of the PRRSV-neutralizing response 
could be a so-called glycan-shielding phenomenon as proposed for the human and 
simian immunodeficiency viruses. “Glycan shielding” may be a primary mechanism to 
explain evasion from NAbs, ensuring in vivo persistence of these viruses (Wei et al., 
2003). Also, observations using field strains of PRRSV appear to support the role of 
N-linked glycosylation sites in interfering with the neutralizing antibody response. 
Spanish PRRSV strains have evolved from 1991 to 2005 and there has been a trend to 
gain two glycosylation sites in N37 (Asp) and N53 (Asp) flanking the major 
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neutralizing epitope of GP5 compared to LV strain, consistent with selection of strains 
inducing weaker NAb responses (Mateu et al., 2006). Together, these findings support 
the suggestion that natural infection with PRRSV may involve an immune evasion 
strategy in which few NAbs are produced, and/or large amounts of PRRSV NAbs in 
sera of PRRSV-infected animals may be unable to react with virions due to blocking or 
shielding of the neutralizing epitope by the glycan moieties on GP5 (Ansari et al., 
2006) .  
Cell-mediated immune (CMI) response to PRRSV determined by lymphocyte 
blastogenesis and adaptive cytokine production is delayed, primarily detectable in the 
in vitro recall response of PBMC around 1-2 weeks after infection (Bassaganya-Riera 
et al., 2004; Bautista and Molitor, 1997; Charerntantanakul et al., 2006; Lopez Fuertes 
et al., 1999; Meier et al., 2003; Royaee et al., 2004). Infection with PRRSV has been 
shown to increase the numbers of various peripheral blood mononuclear leukocyte 
subsets (Albina et al., 1998b; Diaz et al., 2005), beginning with an increase in CD8α+ 
cells, 1week after infection, followed by an increase in the numbers of CD4+ and γδ T 
cells, 7 weeks post-infection. The latter was shown to coincide with an increase in the 
number of interferon-γ (INF-γ) producing cells in the peripheral blood (Batista et al., 
2004), an indicator for proliferation of cytotoxic cells. Over the same period, the 
number of effector cells specific for PRRSV was shown to increase, reaching maximal 
levels at 7 weeks post-infection (Bautista and Molitor, 1997). Protective immunity 
against PRRSV is not clearly understood. Various studies suggest that the cell-
mediated immune response is not sufficient to completely eliminate the virus and to 
prevent persistent infection (Batista et al., 2004; Lowe et al., 2005; Murtaugh et al., 
2002). A delay in the appearance of the cellular immune response suggests that 
PRRSV infection involves a mechanism of immunosuppression or immunomodulation 
(Done, 1995; Murtaugh et al., 2002).   
. 
 
 26
 
 
Figure 5. Temporal sequence of events after infection of a pig with PRRSV (Adapted 
from Lopez and Osorio, 2004). 
 
 
6. Disease control and eradication  
 
6.1. Control and eradication strategies  
 
The rapid spread and economic impact of PRRS have made it a frequent topic 
of research, especially regarding its control (Neumann et al., 2005; Zimmerman et al., 
1997). The key elements of a PRRS control and eradication program are early disease 
detection and rapid laboratory confirmation; quick identification of the infected farms 
and control of the infection through different stamping out strategies. As with many 
other infectious diseases, the most effective means of control often depends on the use 
of vaccines as well as the implementation of improved management practices. 
Regarding the first option, there are currently a few commercially available vaccines. 
These include modified live virus (MLV) as well as inactivated-virus or killed virus 
(KV) vaccines. They are all made from cell culture of MARC-145 since MARC-145 
cells have been the most convenient for vaccine production up until now. However, the 
nature of the pig’s immune response to PRRSV makes the development of an 
unquestionably safe as well as highly effective vaccine a formidable challenge. 
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Consequently, in many affected herds, the development of strategies for control and 
perhaps eventual eradication of PRRS depends on a thorough knowledge of the 
epidemiology of the disease and vaccination is only one of several approaches to be 
considered in designing a control strategy (Prieto and Castro, 2005). 
Various control programs have been developed to eliminate the virus from 
infected farms, but no single program is satisfactory for controlling it in all types of 
herds. Programs including partial depopulation (Dee et al., 1997), segregated early 
weaning (Rajic et al., 2001), vaccination with nursery depopulation (Dee et al., 1998), 
and test and removal (T&R) (Dee and Molitor, 1998; Dee et al., 2000) have been 
described, and the T&R technique has been applied successfully to some herds.  
Vaccination and/or partial or total depopulation strategies, test and removal 
procedures or acclimatization of incoming pigs has proven efficient in the eradication 
of PRRS (Dee et al., 2000; Yang et al., 2008). Partial or total depopulation is used as 
an eradication strategy in many farms (Dee and Joo, 1997). PRRSV was efficiently 
eliminated from a seedstock breeding farm and a supplying boar stud by a modified 
test and removal method based on an indirect fluorescent assay (IFA) test to detect 
antibodies (Dee and Molitor, 1998), and a nested reverse transcriptase-PCR (nRT-
PCR) to detect virus nucleic acids (Yang et al., 2008).  
Central to the control of PRRS is prevention of the spread of PRRSV within 
the pig herd. The herd should be stable with a uniform level of immunity throughout 
the herd, with no PRRSV-negative pigs. In breeding herds, the modified live vaccines 
have been used as an aid to creating this uniform immunity. Clinical symptoms are 
reduced and the infection of piglets prior to weaning is prevented (Lopez and Osorio, 
2004).  
Limitations of T&R have been documented (Dee and Molitor, 1998; Dee et al., 
2000), and include a high degree of labor involved in testing an entire herd, and 
diagnostic costs that approach US $10.00/tested sow. Furthermore, a high accurate test 
is required to reduce the impact of animal removal on the productivity and profitability 
of the farm (Dee and Molitor, 1998; Dee et al., 2000). Depopulation is expensive and it 
is only effective if strict biosecurity is applied and if all the pig farms in the affected 
region are following the same strategy. Therefore, a combination of depopulation and 
vaccination is an interesting alternative option for control.  
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6.2. Treatments and prevention 
 
In the acute disease phase, when PRRSV first enters the farm it is important to 
cover the period at risk, which is usually six to eight weeks, with in-feed antibiotics 
and water medication. The broad-spectrum antibiotics, tetracyclines, 
trimethoprim/sulpha, or synthetic penicillins are the medication of choice to treat 
secondary infections. 
Vaccination is a common procedure to minimize economic losses associated 
with this pathogen and to prevent reinfection, and vaccines have been proven to be 
effective in experimental trials (Opriessnig et al., 2005) and field studies (in a 
preferentially homologous rather than heterologous PRRSV strain-specific manner) 
(Mavromatis et al., 1999; Sornsen et al., 1998). Nonetheless, the efficacy of these 
currently used vaccines is somewhat controversial and it is generally well accepted that 
there is a need for improvement in their safety and efficacy. MLV vaccines are still 
able to cause viremia and thus can spread to other pigs, as reported in Denmark 
(Botner et al., 1997; Madsen et al., 1998). The MLV vaccines do not prevent 
reinfection, and even the field virus does not induce a lifelong immunity. Furthermore, 
MLV vaccines do not allow serological discrimination between vaccinated and 
naturally infected pigs. The efficacy of PRRSV KV vaccines is less than ideal. The 
vaccines induce poor CMI response and do not induce an antibody response (measured 
by IDEXX ELISA) (Bassaganya-Riera et al., 2004; Piras et al., 2005; Zuckermann et 
al., 2007). Furthermore, due to the PRRSV genetic diversity and quasispecies 
(Goldberg et al., 2003; Rowland et al., 1999), PRRSV vaccine failures are not 
uncommon in the field, and vaccine efficacy is far from being universal and complete. 
Likewise, due to the continuous mutations affecting the viral genome, the PRRSV has 
the ability to persist in herds for long periods of time (Allende et al., 2000; Goldberg et 
al., 2003). This persistence and variability pose serious challenges for the diagnosis 
and control of PRRSV that might be further complicated by reversion of live vaccine 
viruses into the ancestor wild-type virus and recombination of viruses in the field 
(Botner et al., 1997; Meng, 2000; Nielsen et al., 2001; Storgaard et al., 1999). Overall, 
the characteristics of PRRSV increase the difficulties of PRRS prevention. 
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6.2.1. PRRS Vaccines 
 
PRRSV MLV vaccine is recommended for use in sows and gilts for the 
reduction of viremia or reproductive failure and in piglets for the reduction of viremia 
or respiratory disease. The vaccines are efficacious but induce delayed antibody and 
cell mediated immune (CMI) responses (Charerntantanakul et al., 2006; Foss et al., 
2002; Meier et al., 2004). PRRSV KV vaccines are recommended for use in sows and 
gilts for the reduction of reproductive failure and disorders. 
In comparison, MLV vaccines based on American and European-type viruses 
were originally developed for the control of PRRS in growing pigs. Ingelvac PRRS 
ATP (Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO) vaccine based on 
atypical PRRS parent strain is a non-adjuvanted vaccine licensed for use in 3-18 weeks 
old animals. In experimental and field trails, vaccination reduced gross lung pathology 
in 9/9 trials and had from 54%- 97% reduction of gross lesions as compared to 
unvaccinated controls (significance level P<0.05) (Bulletin of Boehringer Ingelheim 
Vetmedica Inc., St. Joseph, MO).  
Porcilis PRRS (Intervet/Schering-Plough Animal Health Wim de Körverstraat, 
Netherlands) vaccine containing European DV strain is a Diluvac Forte adjuvanted 
vaccine and is authorized for use in both fattening and breeding pigs. Field trails 
reported a mortality, a reduction daily weight gain and as being proved “safe” in 
vaccinated pigs (http://www.porcilis-prrs.com/spc-porcilis-prrs.asp). Experimental and 
field studies have demonstrated that the vaccination of young pigs confers protection 
against clinical disease but not against infection (Gorcyca et al., 1995; Labarque et al., 
2004; Mavromatis et al., 1999; Mengeling et al., 2003; van Woensel et al., 1998). 
Several experimental PRRSV vaccines have been developed to improve 
existing vaccines. These include DNA, recombinant peptide, and synthetic peptide 
vaccines. DNA vaccines were demonstrated to induce antibody and CMI responses 
and have some efficacy in protecting pigs from developing viremia and respiratory 
diseases (Pirzadeh and Dea, 1998; Rompato et al., 2006; Xue et al., 2004) 
Recombinant and synthetic peptide vaccines are not as potent and efficacious as MLV 
and DNA vaccines. They require numerous injections, and yet do not confer protection 
(Charerntantanakul et al., 2006; Pirzadeh and Dea, 1998). 
Recent interest in improving immune response to PRRSV vaccines is the 
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utilization of vaccine adjuvants. Several kinds of vaccine adjuvants such as cytokines, 
chemical reagents, and bacterial products, have been studied for their ability to 
potentiate immune response to PRRSV vaccines. These vaccine adjuvants possess 
either T helper 1 (Th1) or Th2 inducing properties and some of them also possess 
innate immune stimulatory property (i.e. APC activation and pro-inflammatory 
cytokine production) (Charerntantanakul, 2009). These adjuvants have been tried in 
commercial PRRSV MLV vaccine (Ingelvac® PRRS MLV, Boehringer Ingelheim, St. 
Joseph, MO)(Charerntantanakul et al., 2006; Foss et al., 2002; Meier et al., 2004; 
Royaee et al., 2004), in-house KV vaccine (Linghua et al., 2007; Linghua et al., 2006; 
Zhang et al., 2007), DNA vaccine (Rompato et al., 2006; Xue et al., 2004), and 
recombinant and synthetic peptide vaccine (Charerntantanakul et al., 2006; Hyland et 
al., 2004). However, only some of them resulted in enhanced immune response or 
increased vaccine efficacy. Future studies are, therefore, required to seek new vaccine 
adjuvants that can potentiate immunogenicity and protective efficacy of PRRSV 
vaccines. 
 
7. Diagnosis of PRRSV infection  
 
A diagnosis of PRRSV infection is based on typical clinical signs, 
seroconversion, characteristic microscopic lesions and the demonstration of PRRSV 
genome and antigens by virus isolation, in situ hybridization (ISH) and reverse 
transcriptase polymerase chain reaction (RT-PCR) methods. 
Serologic tests used in the diagnosis of PRRSV infection include the indirect 
fluorescent assay (IFA) test, serum neutralization (SN) test, immunoperoxidase 
monolayer assay (IPMA), and enzyme-linked immunosorbent assays (ELISA) such as 
commercially available kits (HerdChek-PRRSV, IDEXX Laboratories Inc., 
Westbrook, ME)(Collins et al., 1996).  
In addition to the serologic tests such as ELISA, molecular biology diagnostic 
assays such as RT- PCR are the most frequent assays used for diagnosis of PRRSV. 
RT-PCR is better used for samples that cannot be used in cell cultures such as semen 
and samples in which PRRSV infectivity has been reduced, such as autolytic tissue. 
Restriction fragment length polymorphism analysis of PCR-amplified products was 
developed for the differentiation of field and vaccine PRRSV isolates (Wesley et al., 
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1998). Recently, real-time PCR for quantification of PRRSV in naturally infected and 
challenged pigs was also reported (Chung et al., 2005) and reverse transcription loop-
mediated isothermal amplification assay (RT-LAMP) was developed for rapid PRRSV 
detection (Li et al., 2009). 
The correlation between the onset of clinical signs and pathological lesions, 
PCR positivity and other diagnostic techniques gives stronger evidence of PRRSV 
infections. 
 
 
  
 
 
  
 
 
 
 
 
 
III. MATERIALS, METHODS & 
RESULTS 
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Abstract 
 
Airborne transmitted pathogens, such as porcine reproductive and respiratory 
syndrome virus (PRRSV), need to interact with host cells of the respiratory tract in 
order to be able to enter and disseminate in the host organism. Primary porcine 
alveolar macrophages (PAM) and immortalized MARC-145 (a monkey kidney cell) 
cell lines are known to be permissive to PRRSV replication in vitro. MARC-145 cells 
are the more suitable cells for large-scale virus production in vitro.  However, no 
epithelial cell of the respiratory tract of swine had been reported to be permissive to 
PRRSV infection and replication in vitro. The goal of this study was to determine if 
epithelial cells of the respiratory tract of swine could support PRRSV replication in 
vitro. Interestingly, an epithelial cell line of the respiratory tract of swine, the SJPL, 
was found to be permissive to PRRSV infection and replication.  Following PRRSV 
replication, the amount of infectious PRRSV particles produced in infected SJPL cells 
compared to infected MARC-145 cells was similar. The SJPL cells were able to permit 
the replication of several PRRSV North-American strains but they were slightly less 
efficient for virus isolation than MARC-145 cells. In addition, the SJPL cells were 8 to 
16 times more sensitive to the antiviral effect of IFN-α against PRRSV replication 
than MARC-145 cells. In conclusion, the SJPL cells could be an interesting substitute 
to MARC-145 cells for PRRSV vaccine antigens production and they could be a more 
relevant in vitro model because of their origin (lung of the natural host) to study the 
pathogenesis of PRRSV. 
 
Key words: Porcine reproductive and respiratory syndrome virus; PRRSV; porcine 
lung epithelial cell; SJPL; virus replication; cell permissiveness 
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1. Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is present worldwide 
and is one of the most economically important infectious diseases of swine production 
(Neumann et al., 2005). PRRS disease was first described in the United States in 1987 
(Keffaber, 1989; Loula, 1991) and a few years later in the Netherlands (Wensvoort et 
al., 1991). The disease has many clinical manifestations but the two most prevalent are 
severe reproductive failure in sows and gilts (characterized by late-term abortions, an 
increased number of stillborns, mummified and weak-born pigs) (Albina, 1997; 
Keffaber, 1989) and respiratory problems in pigs of all ages associated with a non-
specific lymphomononuclear interstitial pneumonitis (Albina, 1997; Keffaber, 1989; 
Rossow et al., 1994). 
The etiological agent, porcine reproductive and respiratory syndrome virus 
(PRRSV) was identified in 1991 by investigators in the Netherlands and shortly after 
in the USA (Benfield et al., 1992; Collins et al., 1992; Wensvoort et al., 1991). The 
PRRSV is an enveloped, single-stranded positive sense RNA virus, approximately 50–
65 nm in diameter classified in the order Nidovirales, family Arteriviridae, genus 
Arterivirus along with equine arteritis virus (EAV), lactate dehydrogenase-elevating 
virus of mice (LDV), and simian hemorrhagic fever virus (SHFV) (Benfield et al., 
1992; Cavanagh, 1997).  PRRSV genome is approximately 15 kb in length. The viral 
RNA genome is capped at the 5’ end and polyadenylated at the 3’ end and encodes at 
least nine open reading frames (ORFs) (Dea et al., 2000), each of which is expressed 
via the generation of a 3’-coterminal nested set of subgenomic (sg) mRNAs 
(Gorbalenya et al., 2006). The virus is genetically, antigenically, and pathogenically 
heterogeneous (Dea et al., 2000; Meng, 2000).  Currently, PRRSV isolates are divided 
into two distinct genotypes, the European genotype (EU) or type I represented by the 
Lelystad virus (LV) and the North American genotype (NA) or type II represented by 
the ATCC VR-2332 strain (Hanada et al., 2005). 
PRRSV is known to have a very restricted cell tropism both in vivo and in 
vitro. In vivo, the virus mainly infects well-differentiated cells of the monocyte-
macrophage lineage, in particular porcine alveolar macrophages (PAMs), the primary 
target cells of virus and interstitial macrophages in other tissues such as heart, thymus, 
spleen and Peyer's patches, hepatic sinusoids, renal medullary interstitium, and adrenal 
gland (Beyer et al., 2000; Duan et al., 1997; Halbur et al., 1995; Halbur et al., 1996). In 
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addition to macrophages, PRRSV RNA and nucleocapsid protein (N) were found by in 
situ hybridization (ISH) in testicular germ cells, endothelial cells in the heart, 
interdigitating cells in the thymus, dendritic cells in the spleen and Peyer's patches 
(Halbur et al., 1995; Sur et al., 1997).  In experimentally infected gnotobiotic pigs, 
PRRSV antigens were found in bronchiolar epithelial cells, arteriolar endothelial cells, 
monocytes as well as interstitial, alveolar, and intravascular macrophages using an 
immunogold-silver immunohistochemical staining (Rossow et al., 1996). PRRSV 
RNAs and antigens were also found in bronchiolar epithelial cells (Pol et al., 1991), 
epithelium-like cells of alveolar ducts (Magar et al., 1993), and pneumocytes (Cheon 
et al., 1997; Pol et al., 1991) in the naturally infected pigs whereas it was not found in 
these types of cells in the experimentally infected pig (Teifke et al., 2001). Tissues 
such as lung, lymphoid tissues, Peyer’s patches, and kidney were also the preferable 
organ targets of PRRSV infection (Haynes et al., 1997; Sur et al., 1996). PRRSV 
distribution is also strain-dependent (Haynes et al., 1997). 
In vitro, PRRSV was originally isolated on primary cultures of PAMs 
(Wensvoort et al., 1991) and so far, these cells as well as freshly isolated blood 
monocytes or monocytic derived dendritic cells (Voicu et al., 1994; Wang et al., 2007), 
remain the only porcine cells that can effectively be used for viral propagation since 
they could be infected by the virus and allow its replication. Only two other non-
porcine permissive immortalized cell lines permit the complete replication cycle of 
PRRSV, the MARC-145 and CL2621 cells (subclones of MA104 monkey kidney cell 
line) (Bautista et al., 1993; Benfield et al., 1992; Kim et al., 1993), which are routinely 
used for in vitro propagation of PRRSV and for large-scale production of PRRSV 
vaccine strains. 
PRRSV can be airborne transmitted over long distances (Dee et al., 2009). 
Airborne transmitted pathogens need to interact with host cells of the respiratory tract 
such as epithelial cells and alveolar macrophages in order to be able to enter and 
disseminate in the host organism. If PRRSV is airborne transmitted and PRRSV 
antigens and viral RNA can be detected in epithelial cells of the respiratory tract of 
infected pigs, than we can speculate that in addition to the alveolar macrophages, 
epithelial cells of respiratory tract could be permissive to PRRSV replication in vitro. 
Nonetheless, no immortalized epithelial cell of the respiratory tract of swine had been 
previously reported to be permissive to PRRSV infection and replication in vitro and 
attempts to find such cells have previously failed (Ferrari et al., 2003; Huang et al., 
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2009; Wensvoort et al., 1991). The goal of this study was to determine whether 
immortalized epithelial cells of the respiratory tract of swine could support PRRSV 
replication in vitro and eventually if they could be used as a more suitable model for 
studying the pathogenesis of PRRSV and as an alternative method for PRRSV vaccine 
antigens production compared to MARC-145 cells.  
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2. Materials and methods 
 
2.1. Cells and viruses 
 
MARC-145 cells, which is a subclone of the African green monkey kidney 
MA104 cells that is highly permissive for PRRSV (Kim et al., 1993), were maintained 
as previously described (Kheyar et al., 2005). The porcine lung epithelial cell line 
(SJPL) was kindly provided by Dr R.G. Webster (St. Jude Children's Hospital, 
Memphis, TN, USA) (Seo et al., 2001). This cell line was cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) (Invitrogen Corporation, GibcoBRL, Burlington, 
ON, Canada) supplemented with 10% fetal bovine serum (FBS) (Wisent Inc, St-Bruno, 
QC, Canada), 1% sodium pyruvate, 1% L-glutamine, 1.4% MEM nonessential amino 
acids, 300U/mL of penicillin, 300 mg/mL of streptomycin and 1% antibiotic-
antimycotic solution (Invitrogen Corporation, GibcoBRL) as previously described 
(Seo et al., 2001). The newborn pig trachea epithelial cell line (NPTr), kindly provided 
by Dr. M. Ferrari (Instituto Zooprofilattico Sperimental, Brescia, Italy), was cultured 
in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen Corporation, 
GibcoBRL) supplemented with 10% FBS (Wisent Inc), 1% sodium pyruvate, 1% L-
glutamine, 1.4% MEM nonessential amino acids, 1% antibiotic-antimycotic solution, 
300U/mL of penicillin and 300 mg/mL of streptomycin (Invitrogen Corporation, 
GibcoBRL) as previously described (Ferrari et al., 2003). The PK15A (porcine kidney) 
cells were used as a control to assess the infectivity of the porcine circovirus type 2 
(PCV-2). The PK15A cells, a subclone of PCV noninfected PK15 cells were 
maintained as previously described (Gagnon et al., 2008) in Earle’s minimal essential 
medium (MEM) (Invitrogen Corporation, GibcoBRL), supplemented with 10% FBS 
(Wisent Inc), 300 U/mL of penicillin, 300 mg/mL of streptomycin, 0.1 mM 
nonessential amino acids, 1 mM sodium pyruvate, 2.5 mg/mL of amphotericin B, and 
10 mM HEPES buffer (Invitrogen Corporation, GibcoBRL). All cell lines were 
cultured at 37°C in 5% CO2 atmosphere. 
The PRRSV strain used to establish the permissiveness of the SJPL cells was 
the MARC-145 cells adapted IAF-Klop North American reference strain (Gagnon et 
al., 2003). The PRRSV virus stock was obtained following three cycles of freeze-thaw 
of PRRSV IAF-Klop infected MARC-145 cells. Afterward, the virus was purified 
following a 3.5 hrs period of ultracentrifugation on a 30% sucrose cushion (in a TBS 
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solution: 50mM tris pH7.5, 150mM NaCl) using the SW28 Beckman Coulter rotor at 
83,000 relative centrifugal force (rcf). The virus pellets were resuspended in 0.5 mL of 
PBS and aliquots of the virus stock were then conserved at –70°C for future use. The 
infectious dose of the virus stock was calculated from a 96-well microplate of MARC-
145 infected cells by the Kärber method as previously described (Gagnon et al., 2008). 
Virus titers were expressed in tissue culture infectious dose 50 per mL (TCID50/mL). 
The FMV-06-1717 PCV-2b strain (Gagnon et al., 2008) has been used in the 
coinfection experiment. The PCV-2 viral stock has been produced as previously 
described (Gagnon et al., 2008). 
 
2.2. Immunofluorescence assay (IFA) 
 
The presence of PRRSV antigens in infected cells was determined by an 
immunofluorescence assay (IFA). Briefly, cells were infected with IAF-Klop PRRSV 
strain at a multiplicity of infection (MOI) of 1. Then, infected cells were fixed at 72 hrs 
post-infection (pi) with a 4% paraformaldehyde (PFA) solution prepared as previously 
described (Ausubel et al., 2002). Mock-infected cells were included as negative 
controls. After an incubation period of 30 minutes at room temperature, the PFA 
solution was removed and cells were washed three times with a phosphate buffer 
saline solution (PBS). Then, cells were incubated during 10 minutes at room 
temperature with a PBS solution containing 1% Triton X-100. After removing the 
Triton X-100 solution, the cells were washed three times with a PBS-Tween 20 
solution (PBS containing 0.02% Tween 20). After the permeabilization procedure, 
cells were incubated 30 minutes with PBS containing 0.2% Tween 20 and 1% Fetal 
Bovine Serum Albumin. Then, the α7 rabbit monospecific antisera (a specific anti-N 
PRRSV protein antibody) (Gagnon et al., 2003) was diluted 1/200 in the washing 
buffer and added to the cells and incubated at room temperature for a 30 minutes 
period. Cells were then washed and were incubated for 30 minutes with the washing 
buffer containing a 1/160 dilution of anti-rabbit specific antisera FITC conjugated 
(Sigma-Aldrich Inc., St-Louis, USA). Finally, cells were visualized using a DMI 
4000B reverse fluorescence microscope, image of the cells were taking with a DFC 
490 digital camera and the image were analyzed using the Leica Application Suite 
Software, version 2.4.0 (Leica Microsystems Inc., Richmond Hill, Canada). The same 
techniques was used to detect the capsid protein (cap) of PCV-2 in the coinfection 
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experiment, except that a specific polyclonal pig serum was used as the primary 
antibodies (diluted 1/200) (Racine et al., 2004) and an anti-swine PE conjugated 
antibody (Abcam Inc., Cambridge, USA) was used as the secondary antibodies 
(diluted as suggested by the manufacturer).  
 
2.3. Virus production during multiple cell passages 
 
Twenty-five cm2 Flasks (Corning Inc., NY, USA) were seeded with 106 
MARC-145 or SJPL cells and those cells were infected with 0.005 MOI of IAF-Klop 
PRRSV strain. The cytopathic effect (CPE) was observed by light microscopy every 
day until the end of the experiment at 5 days pi. Then, cells with their supernatants 
were subjected to three cycles of freeze-thaw at -70°C and the virus stock solutions 
were kept at -70°C for future use. Four subsequent viral passages in MARC-145 and 
SJPL cells were done as previously described except that a dilution of 1/20 of the 
previous viral stock solutions was used for cell infection. Mock-infected cells were 
included as controls in each passage. The amount of virus production at each passage 
was calculated from a 96-well microplate of MARC-145 infected cells by the Kärber 
method and the results were expressed in tissue culture infectious dose 50 per 106 
infected cells (TCID50/106 cells). 
 
2.4. Virus replication kinetics assay 
 
105 MARC-145 and SJPL cells were infected with PRRSV IAF-Klop strain 
using an MOI of 1. The inoculums were removed after 4hrs of incubation. Cells were 
washed three times with culture medium and fresh cell culture medium was added. At 
different times point post infection (0, 4, 9, 12, 18, 24, 48, 72, 96 and 120hrs p.i.), both 
supernatants (cell culture medium) and cell pellets (cells) were collected after 
centrifugation. Then cell pellets and supernatants were stored at -70°C until used. 
Three cycles of freeze-thaw were performed to release infectious viral particles from 
the supernatants and cell pellets. Afterwards, supernatants and cell pellets were 
centrifuged at 4000 rpm at 4°C during 10 min to remove cellular debris and virus 
titration was performed in MARC-145 cells as described above. Mock-infected cells 
were included in each experiment as controls. All experiments were repeated two 
times in triplicate. 
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2.5. Virus isolation 
 
Virus isolation (VI) was attempted from 22 swine samples (lung and lymph 
nodes tissues) submitted from October 2007 to September 2008 to the Veterinary 
virology diagnostic laboratory of the Veterinary college of the Université de Montréal. 
Those samples originate from 3 to 10 weeks old animals housed in different Canadian 
farms and they were submitted for different reasons such as PRRSV outbreaks, porcine 
circovirus associated disease outbreaks, or others health problems. Three of the 
submitted samples were PRRSV negative by a commercially available real-time PCR 
diagnostic assay (Tetracore Inc., Rockville, MD, USA) and the amount of infectious 
PRRSV contained in the 19 real-time PCR positives cases was determined using the 
same assay as previously described (Gagnon et al., 2008). For VI, about 1-2 cm3 of 
pool of tissue samples were homogenized and resuspended in 9 mL of culture medium 
without FBS. Then, three cycles of freeze-thaw at -70°C were performed and tissues 
homogenates were centrifuged at 4000 rpm for 10 min. The supernatants were 
collected and filtered (with a filter size of 0.2 micron). Following the sample treatment, 
cell culture media of confluent MARC-145 and SJPL cell monolayers of 25 cm2 flasks 
(around 106 cells) were removed and 1 mL of filtered sample was added with 1 mL of 
culture medium without FBS. Afterwards, the cells were incubated at 37°C with 5% 
CO2 atmosphere for a 4 hrs absorption period.  Then, the virus inocula were removed 
and cells were washed three times with a sterile PBS solution. Six mL of fresh culture 
medium were added and cells were incubated for 5 days. Then, three cycles of freeze-
thaw were realized at -70°C and cell lysates were centrifuged at 4000 rpm for 10 min. 
Supernatants of cell lysates were collected and used for a subsequent cell infection 
cycle. Briefly, 1 mL of the cell lysate supernatants was resuspended in 1 mL of cell 
culture medium and inoculated to a freshly prepared cell culture. Then, after a 4 hrs 
absorption period, 4 mL of cell culture medium was added onto cells and cells were 
incubated at 37°C with 5% CO2 atmosphere for 5 days. This new infection step was 
done for three consecutive times. At the fourth passage, the VI status was confirmed 
by the presence of CPE and a positive IFA result. To further characterise the PRRSV 
strains that were isolated from both cell lines, PCR products encompassing the ORF5 
gene were obtained from tissues and fourth VI cell passages, and subsequently 
sequenced. Sequences were analyzed using the CLUSTAL W alignment method of the 
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BioEdit sequence alignment editor version 7.0.9 software (Ibis Therapeutics, Carlsbad, 
CA, USA). 
 
2.6. Apoptosis 
 
Confluent monolayers of MARC-145 and SJPL cells were infected with 
PRRSV IAF-Klop strain at 0.5 MOI or were incubated with a mix of apoptotic 
inducers (500 μg/mL actinomycin D, 60 nM vinblastine sulfate, 100 μg/mL 
cycloheximide and 40 μg/mL puromycin 2HCl; Biomol Research Laboratories Inc., 
Plymouth meeting, PA, USA) as positive controls. Cellular changes associated with 
the infection or the inducers were respectively visualized at 72 hrs pi and 24 hrs post-
incubation under a light microscope (Leica Microsystems Inc.). At this time, cells were 
disrupted in a lysis buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 1 
mM DTT and 100 μM EDTA) for 5 minutes followed by sonication (Sonifier S-450A, 
Branson, Danbury, CT, USA). Then, protein concentrations were measured by a 
Bradford assay following the manufacturer’s instructions (Bio-Rad Laboratories Ltd, 
Mississauga, ON, Canada). Subsequently, apoptosis was assessed by detecting the 
activation of procaspases 3/7 as described by Gagnon et al. (2003), with minor 
modifications. Briefly, a volume of cell lysate corresponding to 50 μg of total cell 
protein was added to the assay buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% 
CHAPS, 1 mM DTT, 100 μM EDTA and 10% glycerol). Then, specific substrate for 
caspases 3/7, the Ac-DEVD-AFC fluorogenic substrate (Biomol Research 
Laboratories Inc.), was added at a final concentration of 200 μM and the rate of 
fluorescence released was monitored with a 96-well plate fluorometer (Synergy HT, 
Biotek, Winooski, VT, USA). The results were expressed as relative fluorescence 
released (relative fluorescence units or RFU) per second per μg of cell lysates. 
 
2.7. Inhibition of PRRSV replication 
 
105 MARC-145, SJPL and PK15A cells were infected in suspension with an 
infectious dose of 1 MOI of IAF-Klop PRRSV and FMV-06-1717 PCV-2b strains 
individually and simultaneously to determine if PCV-2 could inhibit the replication of 
PRRSV in SJPL as previously reported in MARC-145 cells (Chang et al., 2005). The 
infected cells were seeded in 24 wells plates. The CPE was evaluated at different times 
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post-infection and the cells were fixed with PFA at 96 hrs pi and IFA was realized to 
detect the expression of viral proteins of both viruses. To determine the amount of 
porcine IFN-α that is able to inhibit the replication of PRRSV in permissive cell lines, 
104 MARC-145 and SJPL cells were seeded into wells of 96-well tissue culture plates 
(Corning Incorporated) and incubated overnight. The cells were then infected with the 
PRRSV IAF-Klop strain at an infectious dose of 0.5 MOI in a culture medium without 
FBS and incubated during 4 hrs. The culture medium was then removed and replaced 
by a complete medium (ie with 10% FBS) with different concentrations of porcine 
IFN-α (PBL, New Jersey, USA) and incubated during 5 days. Then, the development 
of CPE was monitored and an IFA was realized as described above for the detection of 
PRRSV proteins expression in infected cells. All the experiments were done in 
duplicate. 
 
2.8. Statistical analysis 
 
A two-way ANOVA model, followed by Bonferroni post-hoc tests (Graphpad 
PRISM Version 4.0 software) were used to determine if a statistically significant 
difference exists between MARC-145 and SJPL cell lines in regards to the amount of 
PRRSV produced after multiple cell passages and procaspases 3/7 activation by 
PRRSV. Differences were considered statistically significant with a p<0.05. For the 
viral replication kinetics experiment, the time-course of TCID50 measured from the 
cell pellets and supernatants was analyzed with SAS Version 9.1 software. The 
following linear mixed-effect model for repeated measurements was solved using 
restricted maximum-likelihood estimation (Littell et al., 2006): Yijkl = µ + αi + βj + τk + 
(α·β)ij + (α·τ)ik + (β·τ)jk + (α·β·τ)ijk + R·(α·β)ijl + eijkl. Where Yijkl is the measured 
TCID50; µ is the grand mean; cell line (αi), type of analytical matrix (βj), and sampling 
time (τk) are fixed factors; the experiment replicate (RRl) is a random effect; and eijkl is 
the random error term. As indicated in the equation above, this statistical model 
included all dual and triple interactions between the fixed-effect factors, and the 
random-effect factor RlR  was nested within cell and analytical matrix. The strategy for 
covariance structure modeling proposed by Littell et al (2000) was used. Briefly, the 
model was estimated first with a free covariance structure. After inspecting the 
estimated covariance matrix, the model was estimated anew with more parsimonious 
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covariance models (e.g., compound symmetry, first-order autoregressive), which 
structure resembled that of the unstructured covariance matrix. The heterogeneous 
first-order autoregressive covariance model was selected because it fitted best to the 
empirical covariance matrix, as determined with the Akaike information criterion 
(Littell et al., 2000). Least-square means were used to assess differences between the 
two cell lines at each time and for each type of analytical matrix (i.e., cell pellets or 
supernatants), using Bonferroni-adjusted significance thresholds. The areas under the 
time-TCID50 curves (AUC) were calculated for each cell*matrix*replicate in order to 
obtain estimates of total viral production for each cell line following the 120 hrs 
duration of the experiment. 
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3. Results 
 
3.1. SJPL cells susceptibility to PRRSV 
 
In order to evaluate the susceptibility of epithelial cells of the respiratory tract 
of swine in regards to PRRSV, two epithelial cell lines, the NPTr and SJPL cells, were 
inoculated with PRRSV IAF-Klop strain at 1 MOI. As previously reported, the NPTr 
cells were not permissive to PRRSV (data not shown) (Ferrari et al., 2003). 
Surprisingly, the PRRSV-infected SJPL cells developed a very light CPE at 72 hrs pi 
compared to mock infected cells as illustrated in Figure 1, which suggested the 
replication of PRRSV. The amount of CPE observed in SJPL cells increases over time 
but it has been always significantly smaller compared to PRRSV-infected MARC-145 
cells (data not shown and Figure 1). To confirm the PRRSV proteins expression in 
infected SJPL cells, an IFA was performed. Interestingly, the PRRSV N protein was 
detected in PRRSV-infected SJPL cells (Figure 1) which indicate that PRRSV was 
able to express at least the N viral protein. Most of the IFA positive cells have positive 
signal localized in the cytoplasm (Figure 1) such as what have been previously 
reported for infected MARC-145 cells (Magar et al., 1995). 
 
3.2. Infectious PRRSV particle production in infected SJPL cells 
 
To establish if SJPL cells allow full PRRSV replication cycle and infectious 
particles production after being in contact with infectious virions, the amount of 
infectious PRRSV particles produced by infected SJPL cells was evaluated during five 
consecutive passages. As illustrated in Figure 2, the amount of infectious virus yield 
from the inoculum (103.3 TCID50/106 cells) compared to the first passage in SJPL cells 
(106.6 TCID50/106 cells) increased around 2000 times which clearly indicates that SJPL 
permits the production of infectious viral particles. The amount of virus yield was 
maintained during subsequent passages which further indicates that infectious PRRSV 
particles are produced (Figure 2). However, the overall production of infectious 
particles in SJPL cells compared to MARC-145 cells do not seems to be significantly 
different (P>0.05). 
In order to determine the efficiency of PRRSV production in SJPL cells 
compared to MARC-145 cells, a replication kinetics experiment has been conducted 
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where the amounts of infectious viruses produced in the cell culture medium 
(supernatant) and in the cells (cell pellet) were evaluated at different times pi (Figure 
3). The repeated-measures linear mixed model for analyzing the time-course of 
TCID50 in cell pellets and supernatants (Figure 3) revealed a significant effect of time 
(P<0.0001): on average, viral titers significantly increased by 18 h after inoculation, 
peaked by 48 h and decreased afterwards to values that significantly differed with 
respect to the first measurement time (P<0.0001). Three significant dual interactions of 
fixed-effect variables were recorded: cell*matrix (P=0.0224), cell*time (P=0.0006), 
and matrix*time (P<0.0001). With respect to the cell*matrix interaction, the viral titers 
of SJPL supernatants did not differ significantly from the ones of their cell pellets 
(Bonferroni-adjusted least-square difference; P=1), but the ones of MARC-145 
supernatants were 0.23±0.08 TCID50 units higher than the ones of their cell pellets, an 
almost significant difference (P=0.0628). The viral titers of the SJPL cell pellets were 
0.22±0.08 TCID50 units lower than the ones of MARC-145 cell pellets (P=0.0806), but 
those of the SJPL supernatants were 0.51±0.08 TCID50 units lower than the ones of 
MARC-145 supernatants (P<0.01). With respect to the cell*time interaction, least-
square differences of viral titers for a cell line with respect to its peak value recorded at 
48 h revealed that the viral production of SJPL cells was highest between 24 and 96 h, 
viral titers being significantly lower at all other times (P<0.0001). In contrast, the peak 
viral production of MARC-145 cells lasted between 24 and 48 h, with viral titers being 
significantly lower at the all other sampling times (P≤0.0273). With respect to the 
matrix*time interaction (with cell-specific differences taken into account), least-square 
differences in viral titer between supernatants and cell pellets were significant during 
the first 9 h of incubation (P<0.0001) and the 48 h to 120 h interval (P≤0.0002). Thus, 
more infectious viral particles could be collected at 48 hrs pi and later on from the 
culture medium of both infected cells compared to their respective cell pellets (around 
10 times more). Moreover, the AUC of time-TCID50 curves results indicated that the 
overall estimation of PRRSV infectious virion production of the SJPL cells averaged 
98% of those of MARC-145 cells for cell pellets and 90% for supernatants. 
 
3.3. Virus isolation efficiency 
 
From the 19 PRRSV real-time PCR positive cases, 11 PRRSV isolates could be 
obtained using MARC-145 cells compared to 8 with SJPL cells (Table 1). 
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Consequently, the VI efficiency with MARC-145 and SJPL cells were 58% and 42%, 
respectively, suggesting that MARC-145 could be slightly more suitable for PRRSV 
VI from clinical samples. In addition, all VI positive cases with SJPL cells were also 
VI positive with MARC-145 cells. Interestingly, when the amount of PRRSV was 
higher than 500 TCID50 of PRRSV/gram of tissue, the VI efficiency was also very 
high for both cell lines.  More precisely, the VI efficiency for tissues that have > 500 
TCID50 of PRRSV/gram was 100% and 88% for MARC-145 and SJPL cells, 
respectively (Table 1). To further characterize the PRRSV strains that were isolated, 
the ORF5 gene of five cases that were both VI positive with MARC-145 and SJPL 
cells were sequenced. Sequence analyses revealed that all PRRSV strains are NA type 
isolates (data not shown). Interestingly, the nucleotide (nt) identities between the 
tissues and the fourth cell passage in both cell lines of each cases were 100% identical 
indicating that the same PRRSV strains, that were identified initially in the tissues, 
were isolated.  Moreover, at the fourth cell passage, the ORF5 sequences of viruses 
isolated from each porcine tissue homogenate in SJPL and MARC-145 cells were 
100% identical which suggests that SJPL cells allow the isolation of the same strains 
as those isolated with MARC-145 cells. Sequence analyses also revealed genetic 
variability between strains that were isolated from each porcine tissue homogenate 
with SJPL cells (86.4% to 93.2% nt identities) and compared to the PRRSV reference 
strain IAF-Klop (88.3% to 91.0% nt identities).   
 
3.4. SJPL cells susceptibility to PRRSV apoptosis 
 
As illustrated in Figure 4, the SJPL cells are more sensitive to procaspases 3/7 
activation by PRRSV and several apoptotic inducers since the level of SJPL 
procaspases 3/7 activation was 2.7 to 4.4 times higher compared to MARC-145 cells. 
In addition, activation of procaspases 3/7 in PRRSV-infected MARC-145 and SJPL 
cells was 3.5 to 6.2 times higher (p<0.05), respectively, compared to noninfected cells 
(Figure 4).  Even if procaspases 3/7 activation was higher in SJPL cells, at the time the 
cells were disrupted (24 hrs and 72 hrs pi), the CPE was very mild in SJPL cells 
compared to MARC-145 cells since at least 60% of the PRRSV-infected MARC-145 
cells visualized by light microscopy showed CPE (data not shown and Figure 1).  
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3.5. Inhibition of PRRSV replication 
 
Coinfection of PRRSV-infected MARC-145 cells with PCV-2 has previously 
been reported to cause the inhibition of PRRSV replication (Chang et al., 2005). 
Furthermore, this inhibition was associated with the presence of IFN-α that was 
contained in the PCV-2 viral stock (Chang et al., 2005). Thus, a similar result was 
obtained since the presence of PCV-2 was able to block the replication of PRRSV in 
infected MARC-145 cells (Table 2). Surprisingly, the presence of PCV-2 did not block 
the replication of PRRSV in infected SJPL cells using the same experimental 
conditions (Table 2). Then, to evaluate the impact of IFN-α in regards to PRRSV 
replication, different amounts of IFN-α were added in the cell culture media of both 
cell lines. Interestingly, the minimal concentration of IFN-α needed to have an 
antiviral effect against PRRSV replication was 8 to 16 times lower in infected SJPL 
cells (between 3.13 to 6.25 U/mL) compared to infected MARC-145 cells (between 50 
to 78.13 U/mL) (Table 3).   
 
 
 49
4. Discussion 
 
Previous attempts to find porcine immortalized cell lines into which PRRSV 
infectious particles could bind, enter and complete a full virus replication cycle 
including virion production, such as epithelial cell line of the respiratory tract, have 
failed (Ferrari et al., 2003; Huang et al., 2009; Wensvoort et al., 1991). In the present 
study, a new immortalized porcine epithelial cell line of the respiratory tract of swine, 
the SJPL cells (Seo et al., 2001), was found to be permissive to PRRSV infection and 
replication (Figures 1,2 and 3). The SJPL cells have been known to be permissive to a 
variety of sub-types of influenza virus from human, swine, avian and horse origins 
(Seo et al., 2001). From now on, PRRSV can be added to the list of viruses that can 
replicate in SJPL cells. To our knowledge, it is the first time that an immortalized 
epithelial cell line of the respiratory tract of swine has been reported to be permissive 
to PRRSV infection and replication in vitro. Interestingly, the amount of infectious 
virus produced in infected SJPL cells was at least 90% as high as the amount produced 
in infected MARC-145 cells, and their viral production peak was lasting longer than 
the one of MARC-145 cells, suggesting that the SJPL cells could easily replace the 
MARC-145 cells (and related cells that derivate from MA104 cells) in a large scale 
PRRSV live or killed vaccine production. Furthermore, several PRRSV strains of the 
NA genotype that possess various ORF5 sequences could be isolated from pig samples 
and were able to replicate in SJPL cells (Table 1) indicating that SJPL cells could also 
be used for autogenous vaccines production. In addition to the experiments that have 
been conducted with NA PRRSV strains, we have also conducted some experiments 
with an EU reference strain, the Lelystad virus (LV) (data not shown). Interestingly, 
LV SJPL infected cells could also express the N viral protein, which have been 
detected by IFA, and permit the production of PRRSV infectious particles (data not 
shown). As indicated in Table 1, viruses could be isolated from pig tissue samples on 
three occasions only in MARC-145 and not SJPL cells when the amount of PRRSV in 
tissue was at its lowest, suggesting that MARC-145 cells could be more sensitive for 
VI than SJPL cells. Further experiments will have to be conducted to ascertain this 
latest finding. Nonetheless, the SJPL cells were able to allow the replication of several 
PRRSV NA ORF5 genomic variants and the LV reference strain (data not shown and 
Table 1) indicating that at least these cells are permissive to a wide spectrum of 
PRRSV isolates. 
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Phenotypically, the SJPL cells are distinguishable from the MARC-145 cells 
(Figure 4, Tables 1,2 and 3). As reported previously by Chang et al. (2005), PRRSV 
was not able to replicate in PCV-2 and PRRSV co-infected MARC-145 cells (Table 2) 
and this phenomenon could be related to the presence of IFN-α in the PCV-2 viral 
stock that was used to realize the experiments. Moreover, other reports have previously 
demonstrated the antiviral effect of IFN-α in regards to PRRSV (Brockmeier et al., 
2009). Interestingly, PRRSV was able to replicate in PCV-2 and PRRSV co-infected 
SJPL cells (Table 2) suggesting that SJPL cells could be less responsive to the antiviral 
effect of IFN-α. Consequently, different amount of IFN-α were added in the cell 
culture media to evaluate its antiviral effect in regards to both cell lines.  It was found 
that SJPL cells are more responsive to the antiviral effect of IFN-α than MARC-145 
cells (Table 3) suggesting that another undetermined mechanism was involved in the 
inhibition of PRRSV replication by PCV-2 in infected MARC-145 cells. Noteworthy, 
no PCV-2 capsid protein expression could be detected in both PCV-2 infected SJPL 
and MARC-145 cell lines indicating that PCV-2 do not replicate in those cells. 
Many studies have demonstrated that PRRSV induces apoptosis both in vitro 
and in vivo (Choi and Chae, 2002; Kim et al., 2002; Labarque et al., 2003; Miller and 
Fox, 2004; Sirinarumitr et al., 1998; Suarez et al., 1996; Sur et al., 1997; Sur et al., 
1998) and several techniques have been used to demonstrate this phenomenon such as 
procaspase 3 activation in PRRSV IAF-Klop infected MARC-145 cells (Gagnon et al., 
2003).  At 72 hrs pi, the CPE visualized by light microscopy in PRRSV-infected SJPL 
cells was very mild compared to infected MARC-145 cells (Figure 1) and over time, 
the appearance of CPE in infected SJPL cells was significantly delay compared to 
infected MARC-145 cells (data not shown). Consequently, it could be expected that 
the amount of caspase 3 in infected MARC-145 will be higher compared to infected 
SJPL cells. Surprisingly, the opposite situation was observed indicating that SJPL cells 
are more suited for procaspases 3/7 activation than MARC-145 cells even if only mild 
CPE was observed in SJPL cells following PRRSV infection or incubation with 
apoptotic inducers (Figure 4). This latest result clearly demonstrates that SJPL cells are 
phenotypically completely different from MARC-145 cells and that the level of 
procaspases 3/7 activation induces by PRRSV is not related to the level of CPE that 
could be observed by light microscopy. In fact, other cell death mechanisms have been 
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reported to occur in PRRSV-infected cells such as necrosis (Costers et al., 2008; Wang 
et al., 2007). 
As mentioned by Huang et al. (2009), even if MARC-145 cell line is 
permissive for PRRSV propagation in vitro, it is not of pig origin, and thus PRRSV 
infection in the MARC-145 cells may not reflect the actual virus–host interactions. It is 
further supported by the fact that SJPL cells are phenotypically different from MARC-
145 cells (Figures 1 and 4, Tables 2 and 3). Thus, an immortalized epithelial cell line 
of the respiratory tract of swine, such as SJPL cells, could be more convenient to use 
than primary cell cultures, for obvious reasons, and could be a more relevant in vitro 
model than MARC-145 cells to study the pathogenesis of PRRSV. Furthermore, 
PRRSV is an important pathogen of the respiratory tract of swine that favor secondary 
bacterial and virus infections (Rossow, 1998). Even if PRRSV interaction with 
alveolar macrophages plays a crucial role in the virus pathogenesis, its interaction with 
the epithelial cells of the respiratory tract of swine should not be neglected because 
they have been proven to be infected in vivo (Pol et al., 1991; Rossow et al., 1996). 
Thus, studying the PRRSV-SJPL interactions should give us new insight in regards to 
the viral pathogenesis of PRRSV. 
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Figure 1.  Detection of the N viral protein in PRRSV-infected SJPL cells by an 
immunofluorescence assay.  The IFA was done as described in the materials and 
methods section.  Mock-infected cells are illustrated as control in the upper panels.  
Cells infected at 1 MOI with PRRSV IAF-Klop reference strain are illustrated in lower 
panels.  Cells were visualized with visible light (phase contrast) and UV (IFA). 
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Figure 2.  PRRSV infectious particles production in infected SJPL cells following five 
consecutive passages.  PRRSV IAF-Klop strain was serially passaged in MARC-145 
and SJPL cells as described in the materials and methods section.  The amount of the 
infectious viral particles recovered after each passage was determined in MARC-145 
cells.  The virus titers were expressed as TCID50 per 106 cells. The initial viral 
inoculum (inocul) used to infect both cell lines was 103.3 TCID50/106cells. 
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Figure 3.  PRRSV replication kinetics in infected SJPL cells.  MARC-145 and SJPL 
cells were infected at 1 MOI with PRRSV IAF-Klop strain.  At different time pi, the 
infectious viruses recovered from the cell culture medium (or supernatant) and the 
cells (or cell pellet) were titrated in MARC-145 cells.  Experiment was done in 
triplicate. 
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Figure 4.  Procaspases 3/7 activation in PRRSV-infected SJPL cells.  MARC-145 and 
SJPL cells were infected at 0.5 MOI with PRRSV IAF-Klop strain or incubated with a 
combination of four apoptotic inducers (actinomycin D, vinblastine sulfate, 
cycloheximide and puromycin) as a positive control.  At 24 hrs post-incubation with 
the apoptotic inducers, MARC-145 cells have developed high CPE level compared to 
SJPL cells which showed low to mild CPE.  At 72 hrs, PRRSV-infected cells were 
disrupted for the detection of caspase 3 using a specific fluorogenic substrate.  The 
results were expressed as relative fluorescence released (relative fluorescence units or 
RFU) per second per μg of cell lysates.  Mock infected cells were used as control and 
the experiment was done in triplicate.  a,c,d: statistically different (P<0.05) from mock 
infected cells (24 and 72hrs pi) and apoptotic inducers treated cells; b,c: statistically 
different (P<0.05) from PRRSV and mock infected cells (24 hrs); a,b,c: statistically 
different (P<0.05) from PRRSV and mock infected cells (24 and 72hrs pi). 
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Table 1. PRRS virus isolation efficiency from swine samples using SJPL cells
              compared to MARC-145 cells.
MARC-145 SJPL
(TCID50/g) (number isolated/number tested) b (number isolated/number tested)
0-100c 0 / 7 0 / 7
101-500 2 / 6 0 / 6
501-2500 7 / 7 6 / 7 
2501-40000 2 / 2 2 / 2
Total: 11 / 22 8 / 22
aThe PRRSV was quantified as previously described using a real-time PCR assay (Gagnon et al., 2008).
bThe virus isolation were attempted with both cell lines using the same swine tissue homogenates.
cThree cases out of 7 were real-time PCR negative for the presence of PRRSV.
Cell linesAmount of PRRS 
virus in tissuesa
Table I.  PRRSV virus isolation efficiency from swine samples using SJPL cells 
compared to MARC-145 cells  
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Table 2. Inhibition of PRRSV infection in PCV-2 co-infected cells 
PRRSV PCV-2b PRRSV + PCV-2b 
MARC-145 neg pos neg neg
SJPL neg pos neg pos
neg: negative for CPE and PRRSV antigens; pos: positive for CPE and PRRSV antigens.
As a control, PK15A cells were infected with all virus combinations and the cells were only PCV-2 antigens positive by IFA when PCV-2b 
virus was present.
Note: the experiment was done in duplicate.
Cells
Infected cells
Uninfected cells
Presence of cytopathic effect and detection of PRRSV antigens by immunofluorescence
 
Table II. Inhibition of PRRSV infection in PCV-2 co-infected cells 
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Table 3. Minimal concentration of IFNα for the inhibition of
               PRRSV infection
Cells Cytopathic effect inhibition Immunofluorescence inhibition
MARC-145 > 6.25,  < 12.5a > 50,  < 78.13 
SJPL > 0.78,  < 1.56 > 3.13,  < 6.25 
aExpress in U/μl.
Note: the experiment was done in duplicate.
PRRSV infection inhibition
 
Table III.  Minimal concentration of IFN-α for the inhibition of PRRSV infection 
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IV. Discussion 
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In vitro, PRRSV replicates in primary cultures of PAMs and to some extent in 
porcine peripheral blood monocytes (Delputte et al., 2007a; Duan et al., 1997) and 
dendritic cells (Chang et al., 2008). Primary PAM and immortalized African green 
monkey kidney epithelial cells and its derivatives such as MARC-145 are known to be 
permissive to PRRSV replication in vitro (Benfield et al., 1992; Kim et al., 1993). 
MARC-145 and CL2621 cells, both derived from the MA104 monkey kidney cell line 
are also routinely used for in vitro propagation of wild and vaccine strains (Bautista et 
al., 1993; Benfield et al., 1992; Kim et al., 1993). As mentioned by Huang et al. 
(2009), although immortalized African green monkey kidney epithelial cells MA-104 
and cells derived thereof (MARC-145 and CL2621) are known to be permissive to 
PRRSV replication, they are neither of pig origin nor monocyte–macrophage lineage 
(Benfield et al., 1992; Kim et al., 1993) and thus PRRSV infection in the MARC-145 
cells may not reflect the actual virus-host interactions. Porcine monocyte/macrophage 
lineage cells such as PAMs are the target for PRRSV in vivo, and thus are ideal cell 
models for the immunological and pathogenic study of PRRSV. However, due to 
laborious isolation procedure, low viability of the primary cells in vitro, unreliable 
freezing procedures for long-term storage and heterogeneous phenotype of the isolated 
cells, such studies have their flaws (Huang et al., 2009). Our findings are interesting 
because they represent the first time that immortalized epithelial cells of the swine 
respiratory tract are reported to permit infectious PRRS viral particle production. 
Therefore, SJPL could be a more relevant and convenient model for the 
immunological and pathogenic study of PRRSV than other models. 
In the present study, the susceptibility to PRRSV infection of two new porcine 
epithelial cell lines of the respiratory tract (NPTr and SJPL) was evaluated.  Cells were 
infected with the IAF-Klop North American reference strain. SJPL developed a mild 
CPE compared to control (mock infected) at 72hrs post-infection. Following 
performance of an immunofluorescence assay (IFA), surprisingly, expression of the N 
protein could be detected only in SJPL infected cells. This result further confirms CPE 
observations and suggests that SJPL is susceptible to PRRSV infection. Interestingly, 
the number of positive cells was almost the same compared to infected MARC-145 
cells (data not show), probably due to the fact that more affected MARC-145 died and 
were detached from the cell layer which could have lead to the loss of positive MARC-
145 cells (Figure 1).  Afterwards, a multiple passage infectious viral particle 
production experiment was conducted to establish if SJPL cells could allow full 
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PRRSV replication cycle and progeny virion production after being in contact with 
infectious virions. The results showed that PRRSV viral infectious particles were 
produced after 5 consecutive passages in SJPL cells and the amount of viruses 
produced in infected SJPL cells was similar than in MARC-145 infected cells. It is 
noteworthy that the viral production from the low level of inocula reached highest 
levels at the first passage (from a inocula of 103.3 TCID50/106 cells to the first passage 
of 106.6 TCID50/106 cells) (Figure 2). In order to determine the efficiency of PRRSV 
production in SJPL cells compared to MARC-145 cells, a replication kinetics 
experiment was conducted where the amounts of infectious viruses produced in the 
cell culture medium (supernatants) and in the cells (cell pellets) were evaluated at 
different times pi. Both cells, MARC-145 and SJPL, were identical with regards to 
their efficacy to produce infectious viral particles (Figure 3). Following the above 
experiments, it was concluded that SJLP cells were fully permissive to PRRSV 
replication.   
In order to evaluate the permissiveness of SJPL to LV, the European type of 
PRRSV replication, similar experiments were conducted as compared to the IAF-Klop 
strain.  Specifically, the susceptibility of two new porcine epithelial cell lines of the 
respiratory tract (NPTr and SJPL) to LV infection was evaluated. The development of 
CPE was monitored and N proteins expression was detected by an IFA. Interestingly, 
SJPL could express the N protein although the positive signal was weaker and the 
number of positive cells was less compared to IAF-Klop infected cells at 72hrs pi (data 
not show), possibly due to the fact that the N protein Abs which were used in the 
experiments are heterologeneous to the LV strain. Infected-SJPL cells also developed 
mild CPE compared to the control. The viral production efficiency in SJPL was 
successfully evaluated by a viral replication kinetics experiment. No significant 
differences were found between the SJPL and MARC-145 cells in regards to overall 
viral production.   
 Diagnostic findings indicate a high level of pneumonia, with the isolation of 
PRRS virus in complex with a wide variety of other microbial agents (Rossow, 1998). 
PRRSV infection results in secondary infection or predisposes secondary pathogen 
infections (Brockmeier  et al., 2000; Cooper et al., 1995; Wills et al., 2000a). Our 
finding that epithelial cells of the swine respiratory tract are permissive to PRRSV 
replication may predispose establishment of secondary virus or bacterial infections 
which in turn could be the cofactors enhancing clinical signs of the disease syndrome. 
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Work is now underway to determine if PRRSV has an impact with regards to the 
susceptibility of SJPL to secondary bacterial infections in vitro. Most importantly, our 
findings provide a new and interesting in vitro model for studying the pathogenesis of 
multifactorial respiratory disease. 
In comparison to PCV2, PRRSV alone caused much more adverse effects on 
MARC-145 and SJPL cells directly or indirectly. As seen in a previous study, PCV2 
and PRRSV co-infected MARC-145 and PAMs had a CPE reduction effect compared 
to PRRSV alone infected cells (Chang et al., 2005). PCV2 is a potent IFN-α inducer 
and the released IFN-α may contribute to the anti-viral effects to PRRSV in 
PCV2/PRRSV co-infection in MARC-145 (Chang et al., 2005). PRRSV infection dose 
not elicit type I interferon expression in vitro or in vivo (Albina et al., 1998a; Buddaert 
et al., 1998; van Reeth, 1999). The lack of IFN-α response is significant, since IFN-α-
mediated events inhibit PRRSV replication in vitro (Albina et al., 1998a; Buddaert et 
al., 1998) and elevation of IFN-α in vivo by preinfection with PRCV substantially 
attenuates subsequent PRRSV replication (Buddaert et al., 1998). In the present 
study, PRRSV was not able to replicate in PCV-2 and PRRSV MARC-145 co-infected 
cells (Table 2) and this phenomenon could be related to the presence of IFN-α in the 
PCV-2 viral stock that was used to conduct the experiments as reported previously by 
Chang et al. (2005). Moreover, other reports have previously demonstrated the 
antiviral effect of IFN-α with regards to PRRSV(Brockmeier et al., 2009; Chang et al., 
2005). Interestingly, PRRSV was able to replicate in PCV-2 and PRRSV SJPL co-
infected cells (Table 2) suggesting that SJPL cells could be less responsive to the 
antiviral effect of IFN-α. However, it was found that SJPL cells are more responsive to 
the antiviral effect of IFN-α than MARC-145 cells (Table 3). It is noteworthy that no 
PCV-2 capsid protein expression could be detected in both PCV-2 SJPL and MARC-
145 infected cell lines indicating that PCV-2 do not replicate in these cells. Previous 
studies have documented the antiviral effect of IFN-α on PRRSV infection (Buddaert 
et al., 1998; Lee et al., 2004). Effects similar to the present results were described for 
monocyte cultures, where IFN-α also reduced or blocked PRRSV infection of 
macrophages when added before or during inoculation (Delputte et al., 2007a). In 
contrast, these authors observed that monocytes that were cultivated for 2 days with 
IFN-α, followed by 1-day cultivation without IFN-α, showed a remarkably higher 
susceptibility to PRRSV infection (20 fold), up to levels similar to those in 
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macrophages. The effect of IFN-α receptor sialoadhesin on susceptibility of 
monocytes to PRRSV infection is determined by the balance between enhancement of 
infection due to induction of receptor sialoadhesin expression and reduction of 
infection caused by the antiviral action of IFN-α (Delputte et al., 2007a).  Likewise, 
PRRSV attenuates innate immune responses, evades the antiviral cytokine (IFN-α) 
response, and blocks IFN-α production in the cytoplasm of infected alveolar 
macrophages (Mateu and Diaz, 2008). Several mechanisms have been described that 
are used by such viruses as herpesviruses, influenza virus, and hepatitis C virus to 
escape from the IFN system, such as inhibitors of IFN production and signaling (Katze 
et al., 2002; Landolfo et al., 1995; Levy and Garcia-Sastre, 2001). In this study, 
PRRSV may evade the IFN response in PCV2 and PRRSV coinfected SJPL cells or 
another undetermined mechanism may have been involved in the inhibition of PRRSV 
replication by PCV-2 in infected MARC-145 cells. In future studies, it will be 
interesting to establish if a PRRSV receptor sialoadhesin exists in SJPL and whether 
IFN-α treatment can induce a PRRSV receptor sialoadhesin expression in SJPL cells 
which could further enhance SJPL susceptibility to PRRSV infection.  
Apoptosis is one of the molecular mechanisms of eukaryotic cell death. 
PRRSV induces apoptosis both in vitro and in vivo (Choi and Chae, 2002; Kim et al., 
2002; Labarque et al., 2003; Miller and Fox, 2004; Sirinarumitr et al., 1998; Suarez et 
al., 1996a; Sur et al., 1997; Sur et al., 1998) and several techniques have been used to 
demonstrate this phenomenon such as procaspase 3 activation in PRRSV IAF-Klop 
infected MARC-145 cells (Gagnon et al., 2003).  For our primary results, at 72 hrs pi, 
the CPE visualized by light microscopy in PRRSV-infected SJPL cells was very mild 
compared to infected MARC-145 cells (Figure 1) and over time, the appearance of 
CPE in SJPL infected cells was significantly delayed as compared to infected MARC-
145 cells (data not shown). However, our latest results showed that SJPL had higher 
level of response to PRRSV infection in regards to apoptotic inducers compared to 
infected MARC-145 cells (Figure 4). Therefore, the level of procaspases 3/7 activation 
induces by PRRSV is not related to the level of CPE that could be observed by light 
microscopy. In fact, some viruses encode proteins that can inhibit apoptosis through 
inactivation of p53 or binding of Bax and encode anti-apoptotic gene products that 
permit their seemingly undetected replication (Teodoro and Branton, 1997). Several 
viruses encode viral homologs of Bcl-2. These homologs can inhibit pro-apoptotic 
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proteins such as Bax and Bak, which are essential for the activation of apoptosis. 
Examples of viral Bcl-2 proteins include the Epstein-Barr virus BHRF1 protein and the 
adenovirus E1B 19K protein(Polster et al., 2004). Some viruses express caspase 
inhibitors that inhibit caspase activity and an example is the CrmA protein of cowpox 
viruses. Whilst a number of viruses can block the effects of TNF-α and Fas. For 
example the M-T2 protein of myxoma viruses can bind TNF-α preventing it from 
binding the TNF-α receptor and inducing a response (Hay and Kannourakis, 
2002). Furthermore, many viruses express p53 inhibitors that can bind p53 and inhibit 
its transcriptional transactivation activity. Consequently p53 cannot induce apoptosis 
since it cannot induce the expression of pro-apoptotic proteins. The adenovirus E1B-
55K protein and the hepatitis B virus HBx protein are examples of viral proteins that 
can perform such a function (Wang et al., 1995). Moreover, Costers et al. 2008b have 
demonstrated that PRRSV infection resulted in activation of two opposite mechanisms, 
which are anti and pro-apoptotic pathways and that a balance exists between them. 
Anti-apoptotic effects played a major role in the PRRSV early infection of MARC-
145.  In present study, statistical analysis has showed that peak viral production in 
SJPL infected cells last longer time than in MARC-145 infected cells (Figure 3).  
PRRSV-infected SJPL might undergo more anti-apoptosis than pro-apoptosis 
compared to PRRSV-infected MARC-145 cells and therefore, a delayed development 
of CPE was showed in PRRSV-infected SJPL cells.  
So far, several viral receptors candidate or viral binding proteins for PRRSV 
have been described, such as heparan sulphate and sialoadhesin (CD169), binding 
protein vimentin as well as CD163 and CD151 (Calvert et al., 2007; Delputte et al., 
2002; Kim et al., 2006; Kristiansen et al., 2001; Shanmukhappa et al., 2007; 
Vanderheijden et al., 2001; Vanderheijden et al., 2003).  These molecules are known to 
increase susceptibility of cells to PRRSV infection. But which molecules exist on 
SJPL cells surface that will increase SJPL cell permissiveness to PRRSV replication. It 
is strongly recommended to do western blot experiments in order to establish the 
mechanism involved in the permissiveness of SJPL to PRRSV infection.  
Immunological and reverse genetic experiments have shown that viral protein 
glycosylation greatly influences antigenicity, immunogenicity, and protective efficacy 
of PRRSV vaccines and other viral vaccines (Abe et al., 2004; Ansari et al., 2006; 
Chen et al., 2000; Dowling et al., 2007). Moreover, it was documented that the poor, 
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meager and sluggish neutralizing immune response invoked by PRRSV in vivo is, in a 
great part, due to the phenomenon of “glycan shielding” caused by the sugars that 
surround the antigenic sites of the surface glycoprotein GP5 of PRRSV (Wei et al., 
2003). This shielding by the sugar moieties would preclude the host’s antibodies to 
reach and neutralize the immunogenic epitopes, which like the epitope B described on 
the GP5 of PRRSV, interact with the viral receptor on the host cell (Ansari et al., 
2006). Elimination (through a process called “hypoglycosylation”) of selected sugar 
moieties present on the surface of GP5 dramatically enhances the ability of a PRRSV 
strain to invoke a more robust response composed of PRRSV-neutralizing Abs (Ansari 
et al., 2006). Adenoviral-expressed GP5 of PRRSV in 293 cells was different from its 
authentic viral protein (in PRRSV-infected MARC-145 cells) in terms of viral protein 
glycosylation (Gagnon et al., 2003) suggesting that viral protein glycosylation is host 
cell dependent. PRRSV antigens produced in MARC-145 may be different from those 
produced in SJPL cells in terms of protein glycosylation. Consequently, PRRSV 
vaccine production in these two different cell lines could affect vaccine efficiency. 
Further studies are required to identify the viral protein glycosylation difference with 
regards to both cell lines. Most importantly, because SJPL is a swine lung epithelial 
cell, it is an ideal cell line for live or killed vaccine production.   
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Porcine reproductive and respiratory syndrome is a major disease that poses a 
significant threat to the global swine industry. The results from this study will provide 
a new cell model for better understanding the pathogenesis of PRRSV and a new 
method for PRRSV vaccine antigen production as well as virus isolation. 
 A new epithelial cell line derived from the swine respiratory tract, the SJPL 
cell, is fully permissive to PRRSV infection and replication. The amount of infectious 
viral particles produced in SJPL infected cells was similar to the amount produced in 
infected MARC-145 cells suggesting that SJPL cells could easily replace MARC-145 
cells in a large scale PRRSV live or killed vaccine antigens production. Virus isolation 
from swine tissues showed that the new cell line is suitable for isolation of a wide 
range of ORF5 variants and that MARC-145 cells seem more sensitive for VI than 
SJPL cells.  
Furthermore, SJPL cells showed a distinct phenotype compared to MARC-145 
cells. It was found that SJPL cells are more responsive to the anti-viral effect of IFN-α 
than MARC-145 cells and that the level of procaspases 3/7 activation induced by 
PRRSV is not related to the level of CPE that could be observed by light microscopy. 
Since the SJPL cell is from the PRRSV host origin, in vitro interaction between SJPL 
and PRRSV or other respiratory pathogens could represent the real interaction between 
host and pathogens.  This suggests that the SJPL cell is a more ideal or suitable in vitro 
model for studying the pathogenesis of PRRSV than other known permissive cell lines. 
It should be noted that the mechanism involved in the permissiveness of SJPL 
cells to PRRSV infection should be demonstrated. Therefore, in future work, it will be 
interesting to investigate which receptors or protein molecules are responsible for the 
permissiveness of SJPL to PRRSV infection using the information acquired during this 
study and new methodologies. Likewise, regarding the LV, European strain, it is also 
strongly recommended to do some experiments in regards to SJPL cells. 
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